<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">104856</article-id><article-id pub-id-type="doi">10.7554/eLife.104856</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.104856.3</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Multi-omics single-cell analysis reveals key regulators of HIV-1 persistence and aberrant host immune responses in early infection</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Dayeon</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8006-8704</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Choi</surname><given-names>Sin Young</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Shin</surname><given-names>So-I</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>An</surname><given-names>Hyunsu</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Choi</surname><given-names>Byeong-Sun</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6128-7995</contrib-id><email>byeongsun@korea.kr</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Park</surname><given-names>Jihwan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5728-912X</contrib-id><email>jihwan.park@gist.ac.kr</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/024kbgz78</institution-id><institution>School of Life Sciences, Gwangju Institute of Science and Technology</institution></institution-wrap><addr-line><named-content content-type="city">Gwangju</named-content></addr-line><country>Republic of Korea</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04jgeq066</institution-id><institution>Director for Laboratory Diagnosis and Analysis, Chungcheong Regional Center for Disease Control and Prevention, Korea Disease Control and Prevention Agency (KDCA)</institution></institution-wrap><addr-line><named-content content-type="city">Daejeon</named-content></addr-line><country>Republic of Korea</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Hong</surname><given-names>Seunghee</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01wjejq96</institution-id><institution>Yonsei University</institution></institution-wrap><country>Republic of Korea</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Rath</surname><given-names>Satyajit</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/028qa3n13</institution-id><institution>Indian Institute of Science Education and Research (IISER)</institution></institution-wrap><country>India</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>21</day><month>08</month><year>2025</year></pub-date><volume>14</volume><elocation-id>RP104856</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2024-11-05"><day>05</day><month>11</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2024-11-05"><day>05</day><month>11</month><year>2024</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.11.04.621999"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-02-20"><day>20</day><month>02</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.104856.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-06-30"><day>30</day><month>06</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.104856.2"/></event></pub-history><permissions><copyright-statement>Â© 2025, Lee et al</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Lee et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-104856-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-104856-figures-v1.pdf"/><abstract><p>The clearance of human immunodeficiency virus-1 (HIV-1) remains a significant public health challenge due to impaired cellular immune responses and HIV-1 maintenance during acute infection. However, the genetic and epigenetic changes influencing the immune response on host infected cells remain unclear. Here, this study analyzes HIV-1-infected CD4+ T cells from peripheral blood mononuclear cells from people living with HIV-1 during early infection (&lt;6 months) using single-cell RNA and ATAC sequencing. It is observed that HIV-1 hinders the antiviral response, particularly by interfering with the interferon signaling pathway. Multimodal analysis identifies KLF2 as a key transcription factor in infected CD4+ T cells. Moreover, cells harboring HIV-1 provirus are predominantly identified as Th17 cells, which exhibit elevated KLF2 activity. This suggests an increased susceptibility to HIV-1 infection and a constrained immune response due to the quiescent characteristics of these cells. The finding provides insights into the immune mechanisms and key regulators of HIV-1 maintenance in CD4+ T cells during the early stages of infection.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>HIV</kwd><kwd>single-cell RNA sequencing</kwd><kwd>single-cell ATAC sequencing</kwd><kwd>acute infection</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Viruses</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003653</institution-id><institution>Korea National Institute of Health</institution></institution-wrap></funding-source><award-id>2019-NI-067</award-id><principal-award-recipient><name><surname>Choi</surname><given-names>Byeong-Sun</given-names></name><name><surname>Park</surname><given-names>Jihwan</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003653</institution-id><institution>Korea National Institute of Health</institution></institution-wrap></funding-source><award-id>2020-ER5103</award-id><principal-award-recipient><name><surname>Choi</surname><given-names>Byeong-Sun</given-names></name><name><surname>Park</surname><given-names>Jihwan</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003725</institution-id><institution>National Research Foundation of Korea</institution></institution-wrap></funding-source><award-id>RS-2024-00335026</award-id><principal-award-recipient><name><surname>Choi</surname><given-names>Byeong-Sun</given-names></name><name><surname>Park</surname><given-names>Jihwan</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100014188</institution-id><institution>Ministry of Science and ICT, South Korea</institution></institution-wrap></funding-source><award-id>RS-2024-00466906</award-id><principal-award-recipient><name><surname>Choi</surname><given-names>Byeong-Sun</given-names></name><name><surname>Park</surname><given-names>Jihwan</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003625</institution-id><institution>Ministry of Health and Welfare</institution></institution-wrap></funding-source><award-id>RS-2024-00466906</award-id><principal-award-recipient><name><surname>Choi</surname><given-names>Byeong-Sun</given-names></name><name><surname>Park</surname><given-names>Jihwan</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>KLF2 activity and impaired interferon signaling contribute to HIV-1 persistence by restricting antiviral immunity in infected CD4 T cells during early infection.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Each year, approximately 2 million people are infected with human immunodeficiency virus-1 (HIV-1), and about 1.1 million individuals die from HIV-related illnesses. HIV-1 primarily targets CD4+ T lymphocytes, leading to a gradual depletion of this critical T cell population and the eventual onset of acquired immunodeficiency syndrome (<xref ref-type="bibr" rid="bib17">Douek et al., 2003</xref>; <xref ref-type="bibr" rid="bib49">Pantaleo et al., 1993</xref>). Although antiretroviral therapy (ART) helps inhibit HIV-1 replication (<xref ref-type="bibr" rid="bib53">Permanyer et al., 2012</xref>), the persistent presence of the virus causes chronic inflammation, contributing to HIV-related morbidity and mortality (<xref ref-type="bibr" rid="bib55">Peterson and Baker, 2019</xref>; <xref ref-type="bibr" rid="bib76">Zicari et al., 2019</xref>). Additionally, latent proviruses can be reactivated and cause viral rebound if ART is discontinued. As a result, achieving complete clearance of HIV-1 remains a major goal and public health challenge (<xref ref-type="bibr" rid="bib6">Battistini and Sgarbanti, 2014</xref>).</p><p>During HIV-1 infection, cellular immune responses are disrupted, leading to immune cell dysfunction and alterations in the immune cell landscape. Acute HIV infection (AHI) occurs from 3 weeks to 6 months after transmission, following an initial period when the viral load is undetectable (<xref ref-type="bibr" rid="bib21">Fiebig et al., 2003</xref>). Once proviruses integrate into the host genome, they impact the recruitment of regulatory factors, thereby affecting gene expression (<xref ref-type="bibr" rid="bib67">Verdikt et al., 2021</xref>; <xref ref-type="bibr" rid="bib40">Lange et al., 2020</xref>; <xref ref-type="bibr" rid="bib50">Park et al., 2014</xref>). These modifications during AHI play a role in the host cellâs initial immune response and contribute to HIV-1 latency (<xref ref-type="bibr" rid="bib6">Battistini and Sgarbanti, 2014</xref>; <xref ref-type="bibr" rid="bib51">Parker et al., 2023</xref>; <xref ref-type="bibr" rid="bib14">Deeks et al., 2015</xref>). Studying transcriptomic changes during AHI is crucial to identify primary immune responses and regulatory factors that influence HIV-1âs effect on host immune cell function.</p><p>Single-cell RNA sequencing (scRNA-seq) and single-cell Assay for Transposase Accessible Chromatin with high-throughput sequencing (scATAC-seq) are powerful techniques that provide insights into cellular diversity, allowing for high-resolution analysis of gene expression and regulatory landscapes in individual cells (<xref ref-type="bibr" rid="bib74">Yoon et al., 2024</xref>; <xref ref-type="bibr" rid="bib5">Bae et al., 2024</xref>; <xref ref-type="bibr" rid="bib20">Eun et al., 2024</xref>; <xref ref-type="bibr" rid="bib35">Kim and Park, 2021</xref>; <xref ref-type="bibr" rid="bib44">Luo et al., 2022</xref>; <xref ref-type="bibr" rid="bib27">Heumos et al., 2023</xref>). Recent advancements in sequencing technologies have driven numerous studies to uncover biological factors contributing to HIV-1 pathogenesis (<xref ref-type="bibr" rid="bib41">Lee et al., 2021</xref>; <xref ref-type="bibr" rid="bib7">Bradley et al., 2018</xref>; <xref ref-type="bibr" rid="bib8">Bruner et al., 2019</xref>; <xref ref-type="bibr" rid="bib34">Kazer et al., 2020</xref>; <xref ref-type="bibr" rid="bib64">Sun et al., 2023</xref>; <xref ref-type="bibr" rid="bib70">Wei et al., 2023</xref>). However, challenges remain in studying genetic and epigenetic regulation in HIV-1-infected cells: low HIV-1+ CD4+ T cell frequency in peripheral blood mononuclear cells (PBMCs) limits reliable analysis (<xref ref-type="bibr" rid="bib8">Bruner et al., 2019</xref>; <xref ref-type="bibr" rid="bib28">Ho et al., 2013</xref>), ex vivo activation in previous studies does not capture in vivo heterogeneity (<xref ref-type="bibr" rid="bib7">Bradley et al., 2018</xref>; <xref ref-type="bibr" rid="bib42">Liu et al., 2020</xref>; <xref ref-type="bibr" rid="bib23">Golumbeanu et al., 2018</xref>). Additionally, although recent studies have attempted direct ex vivo omics analyses (<xref ref-type="bibr" rid="bib12">Collora et al., 2022</xref>; <xref ref-type="bibr" rid="bib73">Wu et al., 2023</xref>; <xref ref-type="bibr" rid="bib22">Geretz et al., 2023</xref>), integrating these datasets remains difficult due to the varying cell types used in each dataset.</p><p>To address these limitations, we conducted single-cell multi-omics analyses on PBMCs from people living with HIV (PLWH) in the early stages of infection. Using a targeted sequencing strategy, we identified and analyzed HIV-1-infected cells at the single-cell level. Based on these findings, we established a gene regulatory network specific to HIV-1-infected cells. This study highlights multiple immune pathways and regulatory factors mediating the effects of acute HIV-1 infection on immune cell function, offering potential therapeutic targets for complete HIV-1 eradication.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>The single-cell transcriptional landscape of HIV-1-infected cells in early stage of infection</title><p>To uncover immune mechanisms and transcriptional regulation in HIV-1-infected cells, we performed single-cell multi-omics sequencing on PBMCs from nine individuals with early-stage HIV infection (&lt;6 months) (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1A</xref>). Using the 10x Genomics Single-Cell platform, we obtained five scRNA-seq and four snRNA-seq data from single-cell multiome datasets. We integrated scRNA-seq and snRNA-seq data, identifying 16 distinct cell populations based on marker genes (<xref ref-type="fig" rid="fig1">Figure 1A</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1âfigure supplement 1A</xref>). We also observed some variability in the proportions of these cell populations among donors, suggesting inter-individual differences in immune cell composition (<xref ref-type="fig" rid="fig1s1">Figure 1âfigure supplement 1B</xref>). Focusing on CD4+ T cells as main targets of HIV-1, we defined four subtypes: CD4 naive T cells, CD4+ effector memory T cells (CD4 EM cells), T helper (Th)2 cells, and Th17 cells (<xref ref-type="fig" rid="fig1">Figure 1B</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1âfigure supplement 1C, D</xref>). <italic>LDHB</italic> and <italic>SELL</italic> were highly expressed in CD4 naive T cells, whereas CD4 EM cells were characterized by high expression levels of <italic>HLA-DRA</italic> and <italic>GZMK</italic>. Among the activated CD4+ T cells, Th2 cells were identified based on the expression of <italic>STAT6</italic> and <italic>GATA3</italic>, and Th17 cells were annotated based on the expression levels of <italic>RORA</italic> and <italic>STAT3</italic>.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Single-cell transcriptomic analysis of HIV-1 RNA+ cells from early infected.</title><p>(<bold>A</bold>) UMAP plot displays the distribution of PBMCs in early infected patients (<italic>n </italic>= 9), clustered based on transcriptome signatures post-removing batch effects. (<bold>B</bold>) The UMAP plot displays the distribution of 4435 CD4 T cells from early infected patients. (<bold>C</bold>) UMAP of CD4 T cells identifies 3450 uninfected cells and 985 HIV-1 RNA+ cells. (<bold>D</bold>) Volcano plot reveals differentially expressed genes (DEGs) in HIV-1 RNA+ CD4 T cells compared to uninfected cells; red dots signify significant DEGs (adj p-value &lt;0.01). (<bold>E</bold>) Bar plot reveals enriched biological processes and immune pathways in HIV-1 RNA+ CD4 T cells (p-value &lt;0.01) using upregulated DEGs; significance presented as âlog(p-value). (<bold>F</bold>) Heatmap exhibits signaling pathways enriched in CD4 T cell types through gene set enrichment analysis (GSEA); positive scores (dark orange) denote enrichment in HIV-1 RNA+ cells (nominal p-value &lt;0.05 and &lt;0.25) are marked with stars. (<bold>G</bold>) GSEA plots show significant immune pathways in CD4 naive, Th2, and Th17 cells, presenting enrichment score (ES), normalized enrichment score (NES), and false discovery rate (FDR).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104856-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1âfigure supplement 1.</label><caption><title>Single-cell transcriptomic analysis identifies the cell types of PBMCs and subclustered CD4 T cells from early HIV-1-infected patients.</title><p>(<bold>A</bold>) Dot plot illustrates the gene expression of cell type-specific marker genes in all clusters, where the dot size represents the percentage of cells expressing the marker gene, and the color intensity indicates the average expression of the marker gene. (<bold>B</bold>) The proportion of cell types is depicted for each donor. (<bold>C</bold>) UMAP plots of subclustered CD4+ T cells from single-cell RNA-seq data. Each color represents a different donor. The right panel shows the distribution of cells after batch correction using the fastMNN algorithm. (<bold>D</bold>) Dot plot illustrates the gene expression of cell type-specific marker genes in all CD4 subclusters. (<bold>E</bold>) The proportion of HIV-1 RNA+ cells to uninfected cells is depicted for each cell type. The box plot includes the counts of both HIV-1 RNA+ cells and uninfected cells.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104856-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1âfigure supplement 2.</label><caption><title>Single-cell transcriptomic analysis identifies the characteristics of HIV-1 RNA+ cells.</title><p>(<bold>A, B</bold>) Upregulated (red) and downregulated (blue) genes are shown on the map of KEGG PI3KâAKT signaling pathway.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104856-fig1-figsupp2-v1.tif"/></fig></fig-group><p>To identify HIV-1 RNA+ cells, we aligned scRNA-seq reads to the HIV-1 genome. Additionally, we conducted targeted long-read sequencing using the remaining scRNA-seq libraries to improve the sequencing depth of HIV-1 transcripts. We identified 985 HIV-1 RNA+ cells and 3450 uninfected cells. CD4 naive and EM cells showed a higher proportion of HIV-1 RNA+ cells than Th2 and Th17 (<xref ref-type="fig" rid="fig1">Figure 1C</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1âfigure supplement 1E</xref>).</p><p>Gene expression profiling revealed 334 upregulated and 1,002 downregulated genes in HIV-1 RNA+ CD4+ T cells (<xref ref-type="fig" rid="fig1">Figure 1D</xref>), including genes related to T cell activation (<italic>PRDX2</italic>, <italic>PRDX1</italic>, <italic>HLA-B</italic>, <italic>HLA-C</italic>, <italic>HLA-A</italic>, <italic>HLA-F</italic>, and <italic>HLA-E)</italic>, defense responses to viruses (<italic>IFITM3</italic>, <italic>IFITM1</italic>, <italic>IFITM2</italic>, and <italic>MX1</italic>), and interferon-beta responses (<italic>IFITM3</italic>, <italic>BST2</italic>, <italic>IFITM1</italic>, <italic>IFITM2</italic>, <italic>XAF1</italic>, and <italic>SHFL</italic>) (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). Notably, IFITM1 was the most upregulated gene in HIV-1 RNA+ CD4+ T cells. As an interferon-stimulated gene, IFITM1 is known to inhibit HIV-1 replication by interfering with viral entry (<xref ref-type="bibr" rid="bib43">Lu et al., 2011</xref>). This finding indicates that the primary cellular pathways active during acute infection are also engaged in the antiviral response to suppress HIV-1.</p><p>Given that CD4+ T cell differentiation influences HIV-1 survival (<xref ref-type="bibr" rid="bib29">Horsburgh et al., 2022</xref>), we used gene set enrichment analysis (GSEA) to assess subtype-specific responses (<xref ref-type="fig" rid="fig1">Figure 1F</xref>). The GSEA results revealed that interferon-gamma and interferon-alpha responses were upregulated in all CD4+ T cell subtypes upon HIV-1 infection. Additionally, hallmarks related to T cell activation were downregulated in both Th2 and Th17 cells. Additionally, while interferon-alpha responses were enriched, downstream pathways (e.g., PI3âAKTâmTOR) were downregulated in Th17 cells (<xref ref-type="fig" rid="fig1">Figure 1F, G</xref>). Downregulated genes in Th17 cells were linked to PI3KâAKT signaling, while no such enrichment was observed among upregulated genes (<xref ref-type="fig" rid="fig1s2">Figure 1âfigure supplement 2A, B</xref>). These results suggest that activated T cells experience immune dysfunction in early HIV-1 infection, contrasting with the effects observed in naive CD4+ T cells.</p></sec><sec id="s2-2"><title>Characterization of epigenetic changes in HIV-1-infected CD4+ T cells in early infection</title><p>Single-cell multiome technology enables a detailed understanding of cell states by simultaneously profiling transcriptome and epigenetic signatures within the same cell, facilitating the construction of an accurate gene regulatory network by identifying gene expression drivers. A combined UMAP was generated based on chromatin accessibility and gene expression, with cell types annotated using marker genes (<xref ref-type="fig" rid="fig2">Figure 2A</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2âfigure supplement 1A</xref>). Additionally, coverage plots revealed cell type-specific chromatin accessibility for nearby marker genes (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Chromatin accessibility in HIV-1 RNA+ naive and memory CD4+ T cells identified specific patterns, with closed differential accessibility regions (DARs) in naive cells linked to TNF-alpha signaling via NF-ÎºB and open DARs related to HIV-1 Nef protein and signal transduction. In memory CD4+ T cells, closed DARs were related to interferon signaling and negative regulation of viral transcription, whereas open DARs were related to Tat-mediated HIV elongation. When examining genes adjacent to open chromatin regions (<xref ref-type="fig" rid="fig2">Figure 2D</xref>), we observed high chromatin accessibility for <italic>PSMB7</italic> and <italic>CDK9</italic> in naive and memory CD4+ T cells, respectively, both of which interact with the HIV-1 Tat protein (<xref ref-type="bibr" rid="bib3">Apcher et al., 2003</xref>; <xref ref-type="bibr" rid="bib68">Wang et al., 2020a</xref>). Furthermore, the chromatin accessibility of <italic>NR4A2</italic> and <italic>TRIM62</italic>, which negatively regulate HIV-1 (<xref ref-type="bibr" rid="bib61">Sreeram et al., 2022</xref>; <xref ref-type="bibr" rid="bib10">Chen et al., 2023</xref>; <xref ref-type="bibr" rid="bib66">Uchil et al., 2008</xref>), was reduced in HIV-1 RNA+ cells (<xref ref-type="fig" rid="fig2">Figure 2E</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Exploring the epigenetic characteristics of HIV-1 RNA+ cells through single-cell multiome data.</title><p>(<bold>A</bold>) UMAP plot illustrates PBMC distribution in early infected patients (<italic>n </italic>= 8) post-clustering based on transcriptome and epigenome signatures, with batch effects removed. (<bold>B</bold>) Visualization of differential DNA accessibility across 15 cell clusters. Tracks display normalized chromatin accessibility at promoter regions of cluster-specific marker genes. (<bold>C</bold>) Heatmap displays differentially chromatin-accessible regions (DARs) in HIV-1 RNA+ and uninfected cells of naive and memory CD4 T cell types. Right heatmap presents enriched gene ontology for DAR-associated genes. (<bold>D</bold>) Volcano plot shows DARs between HIV-1 RNA+ CD4 T cells and uninfected cells; red dots signify significant DARs, with associated genes displayed. (<bold>E</bold>) Tracks display normalized chromatin accessibility at the promoter regions of key genes (<italic>PSMB7</italic>, <italic>CDK9</italic>, <italic>NR4A2</italic>, <italic>TRIM62</italic>) in HIV-1 RNA+ and uninfected cells.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104856-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2âfigure supplement 1.</label><caption><title>Single-cell multi-omics analysis identifies epigenetic characteristics of scATAC-seq dataset and upregulated transcription factors (TFs) in HIV-1 RNA+ cells.</title><p>(<bold>A</bold>) Violin plot displays the gene expression of marker genes in scATAC-seq dataset. (<bold>B</bold>) The bar plot represents the gene ontologies associated with the target genes of the upregulated TFs in HIV-1 RNA+ cells (p-value &lt;0.01). The significance of these enrichments is expressed as âlog(p-value).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104856-fig2-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-3"><title>Identification of key transcription factors governing HIV-1 infection features</title><p>Following HIV-1 infection, host transcription factors (TFs) regulate immune responses and viral persistence (<xref ref-type="bibr" rid="bib45">Masenga et al., 2023</xref>). To identify key TFs and construct a gene regulatory network associated with HIV-1 infection, we integrated gene expression and chromatin accessibility data from HIV-1 RNA+ CD4+ T cells.</p><p>We found 15 TFs with increased and 24 with decreased regulon activity in HIV-1 RNA+ cells compared to uninfected cells across all CD4+ T cell subtypes (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). We also confirmed the significantly different regulon activity of these TFs by cell type. CD4 naive and EM cells shared similar TF activity profiles, while Th17 and Th2 cells exhibited more comparable patterns (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). KLF2, typically high in naive cells and suppressed in activated cells (<xref ref-type="bibr" rid="bib39">Kuo et al., 1997</xref>; <xref ref-type="bibr" rid="bib65">Takada et al., 2011</xref>; <xref ref-type="bibr" rid="bib52">Pedro et al., 2021</xref>), showed elevated regulon activity in naive and EM cells, with lower activity in Th17 and Th2 cells (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). However, in HIV-1-infected cells, KLF2 activity was upregulated across all subtypes (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Conversely, FOXO1 showed higher regulon activity in Th17 and Th2 cells but was downregulated in HIV-1 RNA+ Th17 and Th2 cells. In HIV RNA+ cells, the TFs KLF2 and JUND showed strong regulatory activity and elevated gene expression (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Additionally, we identified the upregulated target genes of six TFs (KLF2, JUND, STAT1, JUNB, XBP1, MYC) in HIV-1 RNA+ cells (<xref ref-type="fig" rid="fig3">Figure 3D</xref>), which were significantly associated with the defense response to viruses, negative regulation of viral genome replication, and innate immune responses (<xref ref-type="fig" rid="fig2s1">Figure 2âfigure supplement 1B</xref>). As the GSEA result showed different enriched signaling pathways in HIV-1 RNA+ cells by various cell types (<xref ref-type="fig" rid="fig1">Figure 1G</xref>), several key TF-encoding genes (<italic>KLF2</italic>, <italic>FOXO1</italic>, TBL1<italic>XR1</italic>) which regulate PI3KâATK signaling and p53 signaling were also differentially expressed in each cell type (<xref ref-type="fig" rid="fig3">Figure 3E</xref>).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Identifying key regulators of HIV-1 RNA+ CD4 T cells through integrated analysis.</title><p>(<bold>A</bold>) Heatmap depicts relative regulon activity in each CD4 T cell subtype between HIV-1 RNA+ and uninfected cells. Positive values indicate increased activity in HIV-1 RNA+ cells, while negative values represent a decrease. (<bold>B</bold>) Heatmap displays regulon activity levels in each CD4 T cell subtype, with color indicating scaled regulon activity. (<bold>C</bold>) Dot plot displays gene expression of upregulated transcription factors (TFs) in HIV-1 RNA+ cells, with dot size representing the percentage of cells expressing the gene. (<bold>D</bold>) Volcano plot reveals target genes of upregulated TFs in HIV-1 RNA+ cells; pink dots represent DEGs, and red dots indicate target genes of enriched TFs. (<bold>E</bold>) Violin plot illustrates expression of TF-encoding genes in uninfected and HIV-1 RNA+ CD4 T cells across subtypes (*p &lt; 0.01, **p &lt; 0.001, ****p &lt; 0.00001). (<bold>F</bold>) DNA sequences for overrepresented TF-binding motifs in HIV-1 RNA+ T cells compared to uninfected cells. (<bold>G</bold>) Violin plot displays chromVAR motif activity score for enriched motifs. (<bold>H</bold>) TF footprinting profiles show the increased chromatin accessibility near three representative motifs in HIV-1 RNA+ cells. (<bold>I</bold>) Left panel: Tracks display normalized chromatin accessibility at KLF2 gene locus for HIV-1 RNA+ and uninfected cells, with peak-to-gene links bottom of the coverage plot. Right panel: Expression level of KLF2 in each group.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104856-fig3-v1.tif"/></fig><p>The chromatin accessibility data further supported the increased activity of these TFs in HIV-1 RNA+ cells. We calculated TF activity based on chromatin accessibility and identified enriched TF-binding motifs in HIV-1 RNA+ CD4+ T cells using DARs. KLF2-, JUND-, and FOSL2::JUNB-binding motifs were highly enriched in the DARs opened in HIV-1 RNA+ cells (<xref ref-type="fig" rid="fig3">Figure 3F</xref>), along with enhanced TF activity (<xref ref-type="fig" rid="fig3">Figure 3G</xref>). Furthermore, TF footprinting analysis revealed higher chromatin accessibility adjacent to the KLF2-binding motif sites (<xref ref-type="fig" rid="fig3">Figure 3H</xref>). The promoter region of <italic>KLF2</italic> was more accessible, with higher mRNA expression in HIV-1 RNA+ cells than in uninfected cells (<xref ref-type="fig" rid="fig3">Figure 3I</xref>). Furthermore, the putative cis-regulatory element of KLF2 showed more chromatin-accessible peaks in HIV-1 RNA+ CD4+ T cells than in uninfected cells (<xref ref-type="fig" rid="fig3">Figure 3I</xref>). Overall, this multidimensional approach enabled integrating gene expression and chromatin accessibility in the early stage of infection in PLWH, highlighting potential key TFs that regulate HIV-1 transcription in host cells.</p></sec><sec id="s2-4"><title>KLF2 is an essential regulator in the function of HIV-1-infected CD4+ T cells</title><p>Using a multidimensional approach, we identified KLF2 as a key TF within the gene regulatory network of HIV-1 RNA+ CD4+ T cells. KLF2 is reported to be involved in the quiescence, survival, and differentiation of T cells (<xref ref-type="bibr" rid="bib26">Hart et al., 2012</xref>). However, its function in viral infection remains poorly understood. To elucidate the role of KLF2, we curated 88 KLF2 target genes from published chromatin immunoprecipitation (ChIP)-chip, ChIP-seq, and other TF-binding site profiling data, as well as SCENIC regulon datasets. Out of 88 KLF2 target genes, 44 were upregulated in HIV-1 RNA+ cells (<xref ref-type="fig" rid="fig4">Figure 4A</xref>; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1B</xref>). To validate these findings, we analyzed a publicly available single-cell transcriptomic dataset of HIV-infected PBMCs (<xref ref-type="bibr" rid="bib69">Wang et al., 2020b</xref>). Consistently, expression of <italic>KLF2</italic> and a significant proportion of KLF2 target genes, including <italic>LTB</italic>, <italic>PIM1</italic>, and <italic>NRP2</italic>, were also upregulated in HIV-infected CD4+ T cells (<xref ref-type="fig" rid="fig4s1">Figure 4âfigure supplement 1A</xref>). These target genes were mainly associated with negative regulation of apoptotic process and negative regulation of programmed cell death (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Among these significantly upregulated KLF2 target genes, those reported to be involved in the regulation of HIV-1 replication (<italic>PIM1</italic> and <italic>IL32</italic>) (<xref ref-type="bibr" rid="bib18">Duverger et al., 2014</xref>; <xref ref-type="bibr" rid="bib15">Didichenko et al., 2008</xref>), cell proliferation (<italic>TXNIP</italic>) (<xref ref-type="bibr" rid="bib48">Muri et al., 2021</xref>), and the JAK/STAT pathway (<italic>LTB</italic>) also exhibited higher levels of chromatin accessibility in HIV-1 RNA+ CD4+ T cells than in uninfected cells (<xref ref-type="fig" rid="fig4">Figure 4C</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Functional insights into KLF2 upregulation in HIV-1 RNA+ CD4 T cells.</title><p>(<bold>A</bold>) Bar plot displays gene ontologies associated with upregulated KLF2 transcription factor (TF) target genes in HIV-1 RNA+ cells (p-value &lt;0.01); significance expressed as âlog(p-value). (<bold>B</bold>) Violin plot represents expression of upregulated KLF2 TF target genes in uninfected cells and HIV-1 RNA+ CD4 T cells (*p &lt; 0.01). (<bold>C</bold>) Tracks display normalized chromatin accessibility at promoter loci of <italic>PIM1</italic>, <italic>IL32</italic>, <italic>TXNIP</italic>, and <italic>LTB</italic> for HIV-1 RNA+ and uninfected cells, with peak-to-gene links bottom of the coverage plot. (<bold>D</bold>) Dot plot displays ligandâreceptor pairs detected between CD4 and CD8 T cells; red-labeled gene symbols are KLF2 target genes. Circle size indicates p-values, while color represents mean average expression levels. (<bold>E</bold>) Interactions between KLF2 target genes and HIV-1 proteins identified using STRING database. Yellow dots represent human proteins, and red dots represent HIV-1 proteins; line thickness indicates interaction strength.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104856-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4âfigure supplement 1.</label><caption><title>KLF2 target gene expression in HIV-1-infected CD4+ T cells.</title><p>(<bold>A</bold>) Heatmap showing the expression (<italic>Z</italic>-score normalized) of KLF2 target genes across healthy controls and HIV-1-infected individuals with high and low viral loads. Gene expression data were obtained from a published dataset (GSE157829). (<bold>B</bold>) Violin plots showing the expression levels of FOXP1 and GATA3 in HIV-1 RNA+ versus uninfected CD4+ T cells (top, current study). The bottom panel shows expression levels of KLF2 in published dataset (GSE242997), comparing HIV-infected cells treated with latency-reversing agents (LRA) and DMSO controls.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104856-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4âfigure supplement 2.</label><caption><title>Cellâcell interaction in HIV-1-infected CD4+ T cells.</title><p>(<bold>A</bold>) Circos plot shows cellâcell interactions that are upregulated in HIV-1-infected CD4+ T cells. Line thickness represents interaction strength, and arcs are colored by cell types. (<bold>B</bold>) Circos plot shows downregulated interactions in HIV-1-infected CD4+ T cells.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104856-fig4-figsupp2-v1.tif"/></fig></fig-group><p>Considering that CD8+ T cells play a critical role in the immune response against HIV-1 infection during chronic infection (<xref ref-type="bibr" rid="bib25">Gulzar and Copeland, 2004</xref>; <xref ref-type="bibr" rid="bib47">Mudd and Lederman, 2014</xref>), we further attempted to identify specific ligandâreceptor pairs between CD4+ T cells and cytotoxic T lymphocytes to characterize the immune response induced by HIV-1-infected cells (<xref ref-type="bibr" rid="bib25">Gulzar and Copeland, 2004</xref>). Toward this end, we computed significant ligandâreceptor pair interactions between CD8+ and CD4+ T cells using CellPhoneDB (<xref ref-type="fig" rid="fig4">Figure 4D</xref>; <xref ref-type="bibr" rid="bib19">Efremova et al., 2020</xref>). The results indicated a strong interaction between LTB and its receptor (LTBR) in naive CD4+ T cells, whereas other CD4+ T cell subtypes displayed a weaker interaction with cytotoxic CD8+ T cells. LTB expression was also significantly elevated in HIV-1 RNA+ cells (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1B</xref>). Additionally, the NRP2 receptor exhibited heightened levels of interaction between CD4+ and CD8+ T cells, particularly in the effector CD4+ T cell population. <italic>NRP2</italic>, a known target gene of KLF2, is expressed on T cells and modulates immune responses under pathological conditions (<xref ref-type="bibr" rid="bib57">Roy et al., 2017</xref>). Given that KLF2 is involved in immune cell trafficking and adhesion, we used CellChat (v2.1.1) (<xref ref-type="bibr" rid="bib32">Jin et al., 2025</xref>) to identify altered ligandâreceptor interactions between HIV-1-infected CD4+ T cells and innate immune cells during infection. Both effector and central memory CD4+ T cells exhibited increased MIF and ICAM2 signaling with NK cells, which are associated with KLF2-mediated immune modulation and may enhance immune activation by facilitating immune cell adhesion and migration (<xref ref-type="fig" rid="fig4s2">Figure 4âfigure supplement 2A</xref>; <xref ref-type="bibr" rid="bib54">Pestal et al., 2024</xref>; <xref ref-type="bibr" rid="bib60">SenBanerjee et al., 2004</xref>). However, HIV-1-infected CD4+ T cells simultaneously showed reduced CCL5 and CLEC2B signaling, potentially limited monocyte-driven responses and NK cell recruitment (<xref ref-type="bibr" rid="bib24">Gouwy et al., 2011</xref>; <xref ref-type="bibr" rid="bib71">Welte et al., 2006</xref>). These changes in immune interaction may represent a balance between immune activation and evasion, contributing to viral persistence.</p><p>Subsequently, we explored the interactions between the host proteins encoded by KLF2 target genes and HIV-1 proteins. Using the STRING database, we identified 16 KLF2 target genes that encode proteins that directly interact with HIV-1 (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). One of these target genes, <italic>SOCS3</italic>, which encodes a protein exhibiting a strong interaction with the Tat protein, pivotal for viral genome replication (<xref ref-type="bibr" rid="bib2">Akhtar et al., 2010</xref>). Another KLF2 target gene, <italic>PIM1</italic>, which is known as a transactivator of Tat (<xref ref-type="bibr" rid="bib15">Didichenko et al., 2008</xref>), displayed substantial interaction with JUNB and exhibited high gene expression and chromatin accessibility in HIV-1 RNA+ cells (<xref ref-type="fig" rid="fig4">Figure 4C</xref>).</p></sec><sec id="s2-5"><title>Th17 cells exhibit increased enrichment and susceptibility to HIV-1 infection</title><p>In vivo analysis of the states of cells with the HIV-1 provirus integrated into host genome has been a long-standing challenge in HIV research. To address this issue, we defined cells with two or more scATAC-seq reads that aligned to the HIV-1 genome as HIV-1 DNA+ cells. The sequencing reads predominantly aligned to the 5â²- and 3â²-long terminal repeat (LTR) regions of the HIV-1 genome (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). We observed clustered HIV-1 DNA+ cells in a distinct region, indicating that these cells share a similar epigenetic profile (<xref ref-type="fig" rid="fig5">Figure 5B</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5âfigure supplement 1A</xref>). DARs were identified in the cluster enriched with HIV-1 DNA+ CD4+ T cells compared to the remaining CD4+ T cells (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). The genes closest to the DARs that showed increased accessibility levels in the HIV-1 DNA+ CD4+ T cell cluster compared to the corresponding levels in the uninfected clusters were associated with the inflammatory and defense responses, which was in line with the activation of the innate immune response observed in HIV-1 RNA+ cells (<xref ref-type="fig" rid="fig5">Figure 5D</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Epigenetic analysis in HIV-1 DNA+ CD4 T cells.</title><p>(<bold>A</bold>) Bar plot presents scATAC-seq reads aligned to the HIV-1 genome, showing coverage for individual genomic windows (log-scaled, max value: 245). (<bold>B</bold>) UMAP of CD4 T cells based on chromatin accessibility identifies 5535 uninfected cells and 39 HIV-1 DNA+ cells. (<bold>C</bold>) Heatmap displays chromatin accessibility levels of differential accessibility regions (DARs) enriched in HIV-1 DNA+ CD4 T cell cluster. (<bold>D</bold>) Bar plot represents gene ontologies associated with genes near DARs of HIV-1 DNA+ CD4 T cell cluster; significance expressed as âlog(p-value). (<bold>E</bold>) DNA sequences for overrepresented transcription factor-binding motifs in HIV-1 DNA+ CD4 T cell cluster compared to the rest of CD4 T cells. (<bold>F</bold>) Violin plot displays chromVAR motif activity score for enriched motifs. (***p &lt; 0.0001, ****p &lt; 0.00001) (<bold>G</bold>) Bar plots on the left show normalized ATAC reads for individual genes in HIV-1 DNA+ CD4 T cells and uninfected cells. Bottom shows peak-to-gene links; loop color strength signifies significance of links between peak and gene promoter. The right violin plot displays gene expression levels.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104856-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5âfigure supplement 1.</label><caption><title>Single-cell epigenetic analysis identifies HIV-1 DNA+ cells are mostly represented by Th17 cell type.</title><p>(<bold>A</bold>) The ATAC UMAP plot displays the distribution of 5608 CD4 T cells from early infected patients. (<bold>B, C</bold>) The Feature Plot and violin plot indicate gene expression (RORC, STAT3) in CD4 T cells. (***p &lt; 0.0001). (<bold>D</bold>) The tracks display the normalized chromatin accessibility levels at the promoter regions of RORC and STAT3 in all clusters of CD4 T cells.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104856-fig5-figsupp1-v1.tif"/></fig></fig-group><p>Notably, we identified distinctly enriched TF-binding motifs in HIV-1 DNA+ CD4+ T cells and HIV-1 RNA+ CD4+ T cells. The binding motifs for key regulators of Th17 cell differentiation (RORC, STAT3, and RORA) were enriched in HIV-1 DNA+ CD4+ T cells (<xref ref-type="fig" rid="fig5">Figure 5E, F</xref>; <xref ref-type="bibr" rid="bib9">Castro et al., 2017</xref>). These TFs were also reported to regulate viral gene expression by binding to the HIV-1 LTRs (<xref ref-type="bibr" rid="bib72">Wiche Salinas et al., 2021</xref>). Overall, HIV-1 DNA+ cells mostly represented the Th17 cell type (<xref ref-type="fig" rid="fig5s1">Figure 5âfigure supplement 1B, C</xref>), in contrast to HIV-1 RNA+ CD4+ T cells, which belonged to various subtypes. Additionally, we confirmed significant enrichment of the KLF2 TF-binding motif in HIV-1 DNA+ CD4+ T cells, as found for HIV-1 RNA+ CD4+ T cells. Furthermore, we detected increased gene expression levels and chromatin accessibility of <italic>CCR6</italic>, <italic>IL4I1</italic>, <italic>NFKB1</italic>, and <italic>CCR5</italic> (<xref ref-type="fig" rid="fig5">Figure 5G</xref>).</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In response to early HIV-1 infection, various host immune responses are triggered, contingent upon the subtype of CD4+ T cells. Our study utilized scRNA-seq and scATAC-seq datasets to profile PBMCs from early HIV-1-infected patients, revealing specific immune responses and mechanisms in distinct HIV-1-infected CD4+ T cell subsets that contribute to HIV pathogenesis. We further identified key regulators of HIV-1 persistence in CD4+ T cells, offering new targets for complete viral elimination.</p><p>Interferons play a crucial role in the initial antiviral response during early viral infection by upregulating interferon-stimulated genes and activating signaling pathways like JAK/STAT-, PI3K-, and p53-dependent pathways. These pathways facilitate T cell differentiation and selective proliferation of antiviral T cells, effectively inhibiting viral replication and clearing infected cells (<xref ref-type="bibr" rid="bib58">Satarker et al., 2021</xref>). However, our findings indicate that during acute HIV-1 infection, Th2 and Th17 cells exhibit heightened interferon-alpha responses, despite diminished downstream signaling pathways. In parallel, we observed a higher proportion of HIV-1-infected naive CD4+ T cells. Although their baseline transcriptional activity is low, previous studies have shown that naive CD4 T cells are susceptible to HIV-1 infection during the early stage of infection, potentially due to dysfunctional antiviral signaling in resting cells (<xref ref-type="bibr" rid="bib16">Douek et al., 2002</xref>; <xref ref-type="bibr" rid="bib31">Jiao et al., 2014</xref>). These findings suggest a potential immunological malfunction induced by HIV-1, hindering host antiviral responses by disrupting interferon target signaling, akin to strategies observed in other viruses like Influenza, HCV, and HSV (<xref ref-type="bibr" rid="bib33">Katze et al., 2002</xref>).</p><p>In CD4 memory T cells, we observed enriched chromatin accessibility linked to Tat-mediated HIV-1 elongation, concurrent with downregulated interferon-gamma signaling. This underscores HIV-1âs ability to persist in memory CD4+ T cells and evade host antiviral responses early in infection. Through integrated analysis, we identified KLF2 as a pivotal TF within the regulatory network of HIV-1 RNA+ CD4+ T cells. KLF2, known for promoting cellular quiescence and regulating T cell migration, exhibited sustained expression across all HIV-1-infected CD4+ T cell subtypes, including activated cells (<xref ref-type="bibr" rid="bib39">Kuo et al., 1997</xref>). Upregulated KLF2 target genes associated with HIV-1 replication and TXNIP, a cell proliferation inhibitor, further suggest HIV-1âs ability to persist without triggering transcriptional repressors or proliferation. These findings were further supported by analysis of a publicly available scRNA-seq dataset from HIV-1-infected PBMCs, in which a similar upregulation of <italic>KLF2</italic> and KLF2 target genes was observed in HIV-1-infected CD4+ T cells, reinforcing the reproducibility of our results. A recent study identified FOXP1 and GATA3 as transcriptional regulators of HIV-1 RNA expression using both cell line-based and primary CD4+ T cell models (<xref ref-type="bibr" rid="bib4">Ashokkumar et al., 2024</xref>). While these findings highlight transcriptional control in HIV-1 latency, we did not observe notable differential expression of FOXP1 or GATA3 in our dataset (<xref ref-type="fig" rid="fig4s1">Figure 4âfigure supplement 1B</xref>). This discrepancy may reflect differences in infection models, stages, or cellular contexts. Nonetheless, both studies underscore the importance of transcriptional regulation in sustaining HIV-1 persistence.</p><p>Using scATAC-seq data, we differentiated HIV-1 DNA+ CD4+ T cells, revealing enriched TF motifs (RORC, STAT3, RORA) indicative of Th17 cell predominance. These cells, unlike HIV-1 RNA+ CD4+ T cells distributed across various subtypes, exhibited heightened susceptibility and integration of HIV DNA, with increased expression of <italic>CCR6</italic> and <italic>CCR5</italic>âcritical HIV-1 co-receptors (<xref ref-type="bibr" rid="bib56">Richardson et al., 2012</xref>; <xref ref-type="bibr" rid="bib30">HÃ¼tter et al., 2009</xref>). Moreover, enriched KLF2 motifs in HIV-1 DNA+ cells positively regulate <italic>CCR5</italic> expression, along with increased <italic>IL4I1</italic> expression linked to Th17 cell immunosuppression and <italic>NFKB1</italic> involved in HIV-1 genome transcription initiation (<xref ref-type="bibr" rid="bib13">Cousin et al., 2015</xref>; <xref ref-type="bibr" rid="bib11">Coiras et al., 2007</xref>). This suggests Th17 cellsâ potential role as reservoirs due to their susceptibility, quiescent nature, and stem cell-like characteristics.</p><p>Limitations include the inability of our HIV-1 targeted sequencing strategy to distinguish HIV-1 RNA from DNA within single cells, necessitating deeper sequencing to capture transcriptionally silenced proviruses. Our studyâs design focused on early infection stages (&lt;6 months), limiting insights into longitudinal changes in cell populations and gene expression profiles during HIV-1 progression. Given the heterogeneity of HIV-1 infection among PLWH, our findings primarily apply to early infection stages and require validation across different infection phases.</p><p>In summary, our study unveils disrupted immune mechanisms in distinct HIV-1 RNA+ CD4+ T cell subsets and underscores KLF2âs role in HIV-1-infected cells. We propose that this dysregulation enables HIV-1 transcription maintenance while attenuating pathogenic immune responses. Furthermore, Th17 cells may serve as reservoirs due to their heightened susceptibility and KLF2-mediated CCR5 expression. Our findings provide insights into the complex transcriptional and epigenetic changes during HIV-1 infection, informing potential immunomodulatory therapies to restore normal immune responses and enhance viral control in PLWH, thereby limiting disease progression.</p></sec><sec id="s4" sec-type="methods"><title>Methods</title><sec id="s4-1"><title>Preparation of PBMC samples from early infection of PLWH</title><p>PBMCs were collected from a total of nine individuals in the early stages of HIV infection (&lt;6 months). Epidemiological and virological characteristics of these participants at baseline, including sex, age, duration from HIV-1 infection, CD4 T cell count, HIV-1 viral load, and HIV-1 p24 antigen/antibody screening (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1A</xref>).</p></sec><sec id="s4-2"><title>Preparation of scRNA-seq libraries</title><p>The libraries were prepared using the Chromium Single Cell 3â² Library &amp; Gel Bead Kit v2 (PN-120237) (10x Genomics) following the manufacturerâs instructions. The single-cell suspension was washed twice with 1x PBS containing 0.04% BSA. Cell number and viability were determined using the Bio-Rad TC20 cell counter. The cells were loaded onto the 10x Genomics Chromium Controller to generate gel beads in emulsions (GEMs). Library preparation was performed according to the 10Ã Genomics Chromium Single Cell 3â² reagent kit (V2 chemistry) instructions. The quality and concentration of the libraries were assessed using the Agilent Bioanalyzer 2100. Finally, the libraries were sequenced on an Illumina NovaSeq.</p></sec><sec id="s4-3"><title>Preparation of scATAC-seq libraries</title><p>The libraries were prepared using the Chromium Next GEM Single Cell ATAC Library &amp; Gel Bead Kit (PN-1000175) following the manufacturerâs instructions. After isolating the nuclei from PBMCs, the single-nuclei suspension was mixed with Transposition Mix and incubated for 60 min at 37Â°C. Subsequently, the transposed nuclei were combined with the master mix and loaded onto the 10x Genomics Chromium Controller to generate gel beads in emulsions (GEMs). Library construction was performed according to the instructions provided with the Chromium Next GEM Single Cell ATAC Reagent Kits (v1.1). The subsequent steps were performed in the same way as described in âPreparation of scRNA-seq librariesâ.</p></sec><sec id="s4-4"><title>Preparation of single-cell multiome libraries</title><p>The libraries were prepared using the Chromium Next GEM Single Cell Multiome ATAC + Gene Expression Reagent Kits (PN-1000283) (10x Genomics) following the manufacturerâs instructions. Briefly, nuclei were mixed with Transposition Mix and incubated for 60 min at 37Â°C. Then these were loaded onto Chromium Next GEM Chip J (10x Genomics) and GEMs were generated according to the manufacturerâs instructions. After post-GEM cleaned up, barcoded transposed DNA and barcoded full-length cDNA fragments were pre-amplified with PCR. ATAC libraries were constructed using the Library Construction Kit (PN-1000190) and full-length pre-amplified cDNA fragments were additionally amplified via PCR. RNA libraries were constructed using the Library Construction Kit B (PN-1000279). Finally, the libraries were sequenced on an Illumina NovaSeq 6000.</p></sec><sec id="s4-5"><title>HIV-1 targeted sequencing</title><p>After scRNA-seq, remaining scRNA-seq full-length cDNA libraries were subjected to HIV-1 targeted sequencing using the SQK-LSK-109 Ligation Sequencing Kit (Oxford Nanopore Technologies) and three specific primers for HIV-1 (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1C</xref>). The TruSeq Read1 primer was used to preserve the cell barcode information, and the cDNA fragments containing the HIV-1 sequence were amplified by the HIV-1-specific primers. The cDNA fragments with HIV-1 were primarily selected through PCR using biotinylated primers. Subsequently, the HIV-1-specific primers selectively amplified the cDNA fragments through hemi-nested PCR. These selected cDNA fragments were sequenced on a MinION FLO-MIN106 R9.4.1 flow cell (Oxford Nanopore Technologies). Base calling was performed by using Guppy (V6.1.1), and cells with HIV-1 reads were identified using the cell barcode information.</p></sec><sec id="s4-6"><title>Sequence alignment to human and HIV-1 genome</title><p>The reads from scRNA-seq and scATAC-seq were aligned to GRCh38 human genome (v.3.0.0) using CellRanger count (10x Genomics, v.6.1.2) and CellRanger ARC (v.2.0.0) with default options, respectively. Feature-barcode matrices were used for downstream analysis. To identify the sequencing reads containing the HIV-1 sequence, the reads from scRNA-seq were aligned to the HIV-1 genome using the STARsolo (v. 2.7.1a). We adjusted the mapping percentage parameter from 50% to 25% to map the short length of HIV-1 sequence included in the sequencing reads.</p></sec><sec id="s4-7"><title>scRNA-seq data processing</title><p>For the scRNA-seq datasets, Seurat R package (v.3.2.1) was used for processing the raw count matrices (UMI counts per gene per cell) <xref ref-type="bibr" rid="bib62">Stuart et al., 2019</xref>. Prior to feature filtering, DoubletFinder was used to identify and remove putative doublets (<xref ref-type="bibr" rid="bib46">McGinnis et al., 2019</xref>). As in previous studies, standard quality control and preprocessing steps were performed for downstream analysis (<xref ref-type="bibr" rid="bib36">Kim et al., 2024a</xref>; <xref ref-type="bibr" rid="bib37">Kim et al., 2024b</xref>). Cells with fewer than 200 features and greater than 30% mitochondrial gene expression were excluded, and cells expressing fewer than three genes were eliminated. To ensure consistency in quality control and analysis, published scRNA-seq datasets were processed using the same Seurat-based pipeline as described above. Subsequently, the dataset was normalized, highly variable genes were selected, and scaling was performed in Seurat. Batch effects were removed using the âRunFastMNNâ function, and principal component analysis was performed after integrating the datasets. Cells were clustered based on the computed nearest neighbor map using the âFindNeighborsâ function. The clustered cells were visualized on UMAP embeddings. Differentially expressed genes in each cluster were identified using the âFindAllMarkersâ function, and the clusters were annotated using the known cell markers. Clusters were merged if the number of differentially expressed genes was less than 10.</p></sec><sec id="s4-8"><title>scATAC-seq data processing</title><p>For the scATAC-seq datasets, Signac R package (v.1.5.0) was used to process the data (<xref ref-type="bibr" rid="bib63">Stuart et al., 2021</xref>). To ensure common features across the datasets, combined peaks were generated. The transcription start site (TSS) enrichment score and nucleosome signal score were calculated for each cell using the âTSSEnrichmentâ and âNucleosomeSignalâ functions in Signac. Cells were retained with a TSS enrichment score &gt;1 and a nucleosome signal &lt;2 and further filtered the cells containing &lt;1000 or &gt;100,000 ATAC fragments. MACS2 was utilized to identify peaks using each fragment file of datasets (<xref ref-type="bibr" rid="bib75">Zhang et al., 2008</xref>). The datasets were merged, and batch effects were removed using Harmony (<xref ref-type="bibr" rid="bib38">Korsunsky et al., 2019</xref>). The merged dataset was subjected to dimensional reduction with LSI using the âRunTFIDFâ, âFindTopFeaturesâ, and âRunSVDâ functions. The LSI components were used for UMAP projection. The cell type of each cluster was annotated using differentially accessible peaks. To identify significant peaks for each cluster, the âFindAllMarks()â function was employed with the following parameters: min.pct=0.1, test.use = âLRâ, only.pos=TRUE. The âClosestFeature()â function was then used to find the closest genes to each peak within each cluster. Cell clusters were annotated using known cell markers. Subsequently, the scRNA-seq dataset and scATAC dataset from the 10x multiome dataset were integrated using identical cell barcodes to ensure the scATAC-seq clustersâ cell type annotation, leveraging the previously annotated scRNA-seq cell types.</p></sec><sec id="s4-9"><title>Gene ontology enrichment analysis and GSEA</title><p>To identify enriched biological pathways in HIV-1 RNA+ CD4 T cells, DEGs for each cell type were identified using âFindMarkersâ function in Seurat (v.3.2.1). We compared the normalized gene expression data of HIV-1 RNA+ CD4 T cells with uninfected CD4 T cells. All genes that passed quality control were included in the DEG analysis without additional filtering.</p><p>For gene ontology enrichment analysis, DEGs were filtered based on |logFC| &gt;0.25 and adjusted p-value &lt;0.01. Gene ontology enrichment analysis was performed using the web-based tools of DAVID (version DAVID 6.8; <ext-link ext-link-type="uri" xlink:href="http://david.ncifcrf.gov/">http://david.ncifcrf.gov/</ext-link>; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_001881">SCR_001881</ext-link>). Biological processes (BPs) were ranked based on the sets of DEGs in HIV-1 RNA+ cell, considering BPs with a p-value &lt;0.01 significant.</p><p>For GSEA, the raw count matrix was used, and no additional filtering was applied. GSEA was performed to identify the statistically significant gene sets in the HIV-1 RNA+ cell group within different CD4 T cell subtypes. Hallmark gene sets from Molecular Signatures Database (MSigDB) were used, and only gene sets containing 10â500 genes were selected.</p></sec><sec id="s4-10"><title>Gene regulatory network analysis</title><p>To construct a gene regulatory network and predict TF activities from a gene expression dataset, SCENIC (R package, <ext-link ext-link-type="uri" xlink:href="https://github.com/aertslab/SCENIC">https://github.com/aertslab/SCENIC</ext-link>; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_017247">SCR_017247</ext-link>) was utilized as a computational method (<xref ref-type="bibr" rid="bib1">Aibar et al., 2017</xref>). Co-expression modules between TFs and target genes were identified using GENIE3. The cisTarget Human motif database was utilized for scoring the regulons. Subsequently, the AUCell method was employed to score single cells and identify enrichment of regulons in the infection group.</p></sec><sec id="s4-11"><title>Cellâcell interaction analysis</title><p>CellphoneDB was utilized to analyze cellâcell communication between CD4 T cell subtypes and CD8 T cell subtypes (<xref ref-type="bibr" rid="bib19">Efremova et al., 2020</xref>). Interaction pairs with a positive mean expression level in the HIV-1 RNA+ group were selected to explore associations among cell types. The interaction strength was visualized using the âplot_cpdbâ function in the ktplots R package, represented as a dot plot. To identify dysregulated ligandâreceptor signaling, we additionally applied CellChat (v2.1.1) (<xref ref-type="bibr" rid="bib32">Jin et al., 2025</xref>). Differential expression analysis was performed between HIV-1 RNA+ and uninfected CD4+ T cells using the âidentifyOverExpressedGenesâ function. Upregulated and downregulated interactions were determined based on fold-change values.</p></sec><sec id="s4-12"><title>TF-binding motif enrichment and footprinting analysis</title><p>The cells were categorized into three groups: HIV-1 RNA+ cell group, HIV-1 DNA+ cell group, and uninfected cell group. DARs among the groups were identified using the âFindMarkersâ function. DARs with a p-value less than 0.01 between the cell groups were filtered. DARs with a positive log<sub>2</sub> fold-change value were selected for further analysis to identify enriched motifs. Enriched motifs were identified using the motifmatchr (R package, <ext-link ext-link-type="uri" xlink:href="https://bioconductor.org/packages/motifmatchr">https://bioconductor.org/packages/motifmatchr</ext-link>; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_026739">SCR_026739</ext-link>), which involved testing for overrepresentation of each DNA sequence motif in the DARs using a hypergeometric test. The computation of GC contents and matching of background sets of peaks for GC content, sequence length, and counts were performed using the 'FindMotifs' function in Signac. The per-cell motif activity score was calculated by chromVAR for each motif across the infection conditions (<xref ref-type="bibr" rid="bib59">Schep et al., 2017</xref>). For the identification of a strong enrichment of Tn5 integration events adjacent to the enriched motifs, TF footprinting analysis was conducted using the âFootprintâ function in Signac.</p></sec><sec id="s4-13"><title>Statistical analysis</title><p>The subsection above provides a description of statistical analyses for single-cell transcriptomic and epigenetic studies. All descriptive statistical analyses were conducted in R 3.6.0 and higher. BenjaminiâHochberg correction was used for significance.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>Reviewing editor, eLife</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Resources, Data curation, Formal analysis, Visualization, Methodology, Writing â original draft, Writing â review and editing</p></fn><fn fn-type="con" id="con2"><p>Resources, Investigation</p></fn><fn fn-type="con" id="con3"><p>Resources, Investigation</p></fn><fn fn-type="con" id="con4"><p>Resources, Investigation, Methodology</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Resources, Supervision, Funding acquisition, Project administration, Writing â review and editing</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Supervision, Funding acquisition, Project administration, Writing â review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Written informed consent was obtained from all participants. The study was approved by the Korea Disease Control and Prevention Agency (IRB No. 2019-07-06-P-A) and conducted in accordance with the principles of the Declaration of Helsinki.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Patient characteristics, KLF2-associated DEGs in CD4 T cells, and primers for HIV-1 targeted sequencing.</title><p>(<bold>A</bold>) Epidemiological and virological characteristics, and sequencing data information for nine acute HIV-infected patients at baseline. (<bold>B</bold>) Differentially expressed genes overlapped with KLF2 target gene in CD4 T cell (HIV-1 RNA+ vs. uninfected). (<bold>C</bold>) Primers used for HIV-1 targeted sequencing.</p></caption><media xlink:href="elife-104856-supp1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Table of differentially accessible regions between HIV RNA+ CD4 naÃ¯ve T cells and uninfected cells in ATAC-seq data.</title></caption><media xlink:href="elife-104856-supp2-v1.csv" mimetype="application" mime-subtype="octet-stream"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Table of differentially accessible regions between HIV RNA+ CD4 central memory T cells and uninfected cells in ATAC-seq data.</title></caption><media xlink:href="elife-104856-supp3-v1.csv" mimetype="application" mime-subtype="octet-stream"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>Table of differentially accessible regions between HIV DNA+ CD4 T cells and uninfected cells in ATAC-seq data.</title></caption><media xlink:href="elife-104856-supp4-v1.csv" mimetype="application" mime-subtype="octet-stream"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-104856-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>The raw sequencing data (accession number: KAP230707) have been deposited in the Korea National Research Data Archive (KRA) but are not publicly available due to ethical and institutional restrictions associated with human biospecimens. Interested researchers may request access by submitting a data use application via the KRA system. The application, which includes information about the applicant and the proposed research project, will be reviewed and approved by the data depositor (corresponding author: jihwan.park@gist.ac.kr) in accordance with institutional policies. Requests are typically reviewed within approximately 2â4 weeks. Data will be provided for non-commercial academic research purposes only. All software used for data analysis is described in the Methods section. Processed summary data, including differential expression gene (DEG) tables and differential accessibility region (DAR) tables used to generate figures and tables in the manuscript, are provided in <xref ref-type="supplementary-material" rid="supp1 supp2 supp3 supp4">Supplementary files 1â4</xref>.</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Park</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>Study on people living with early HIV-1 infection using multimodal single-cell sequencing analysis</data-title><source>Korea BioData Station</source><pub-id pub-id-type="accession" xlink:href="https://kbds.re.kr/KAP230707">KAP230707</pub-id></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset2"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Hui</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>An Atlas of Immune Cell Exhaustion in HIV-Infected Individuals Revealed by Single-Cell Transcriptomics</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE157829">GSE157829</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset3"><person-group person-group-type="author"><name><surname>Ashokkumar</surname><given-names>M</given-names></name><name><surname>Mei</surname><given-names>W</given-names></name><name><surname>Peterson</surname><given-names>JJ</given-names></name><name><surname>Margolis</surname><given-names>D</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Browne</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>Integrated single-cell multiomic analysis of HIV latency reversal reveals novel regulators of viral reactivation</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE242997">GSE242997</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank all study participants for donating their blood and making this study possible. We are grateful to Jaehyun Seong for preparing this study samples of acute HIV-infected patients. The study samples of acute HIV-infected patients are collected by the Chronic Infectious Disease Cohort Study (Grant Number: 4800-4859-304). This work was supported by the Korea National Institute of Health (Grant Number: 2019-NI-067 and 2020-ER5103), the National Research Foundation of Korea (NRF), funded by the Korean government (Grant Number: RS-2024-00335026), and a grant of the Korea-US Collaborative Research Fund (KUCRF), funded by the Ministry of Science and ICT and Ministry of Health &amp; Welfare, Republic of Korea (Grant Number: RS-2024-00466906).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aibar</surname><given-names>S</given-names></name><name><surname>GonzÃ¡lez-Blas</surname><given-names>CB</given-names></name><name><surname>Moerman</surname><given-names>T</given-names></name><name><surname>Huynh-Thu</surname><given-names>VA</given-names></name><name><surname>Imrichova</surname><given-names>H</given-names></name><name><surname>Hulselmans</surname><given-names>G</given-names></name><name><surname>Rambow</surname><given-names>F</given-names></name><name><surname>Marine</surname><given-names>JC</given-names></name><name><surname>Geurts</surname><given-names>P</given-names></name><name><surname>Aerts</surname><given-names>J</given-names></name><name><surname>van den Oord</surname><given-names>J</given-names></name><name><surname>Atak</surname><given-names>ZK</given-names></name><name><surname>Wouters</surname><given-names>J</given-names></name><name><surname>Aerts</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>SCENIC: single-cell regulatory network inference and clustering</article-title><source>Nature Methods</source><volume>14</volume><fpage>1083</fpage><lpage>1086</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4463</pub-id><pub-id pub-id-type="pmid">28991892</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akhtar</surname><given-names>LN</given-names></name><name><surname>Qin</surname><given-names>H</given-names></name><name><surname>Muldowney</surname><given-names>MT</given-names></name><name><surname>Yanagisawa</surname><given-names>LL</given-names></name><name><surname>Kutsch</surname><given-names>O</given-names></name><name><surname>Clements</surname><given-names>JE</given-names></name><name><surname>Benveniste</surname><given-names>EN</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Suppressor of cytokine signaling 3 inhibits antiviral IFN-beta signaling to enhance HIV-1 replication in macrophages</article-title><source>Journal of Immunology</source><volume>185</volume><fpage>2393</fpage><lpage>2404</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0903563</pub-id><pub-id pub-id-type="pmid">20631305</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Apcher</surname><given-names>GS</given-names></name><name><surname>Heink</surname><given-names>S</given-names></name><name><surname>Zantopf</surname><given-names>D</given-names></name><name><surname>Kloetzel</surname><given-names>PM</given-names></name><name><surname>Schmid</surname><given-names>HP</given-names></name><name><surname>Mayer</surname><given-names>RJ</given-names></name><name><surname>KrÃ¼ger</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Human immunodeficiency virus-1 Tat protein interacts with distinct proteasomal alpha and beta subunits</article-title><source>FEBS Letters</source><volume>553</volume><fpage>200</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1016/s0014-5793(03)01025-1</pub-id><pub-id pub-id-type="pmid">14550573</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashokkumar</surname><given-names>M</given-names></name><name><surname>Mei</surname><given-names>W</given-names></name><name><surname>Peterson</surname><given-names>JJ</given-names></name><name><surname>Harigaya</surname><given-names>Y</given-names></name><name><surname>Murdoch</surname><given-names>DM</given-names></name><name><surname>David</surname><given-names>DM</given-names></name><name><surname>Kornfein</surname><given-names>C</given-names></name><name><surname>Oesterling</surname><given-names>A</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Rudin</surname><given-names>CD</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Browne</surname><given-names>EP</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Integrated single-cell multiomic analysis of HIV</article-title><source>Latency Reversal Reveals Novel Regulators of Viral Reactivation. Genomics Proteomics Bioinformatics</source><volume>22</volume><elocation-id>eqzae003</elocation-id><pub-id pub-id-type="doi">10.1093/gpbjnl/qzae003</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bae</surname><given-names>S-G</given-names></name><name><surname>Yin</surname><given-names>GN</given-names></name><name><surname>Ock</surname><given-names>J</given-names></name><name><surname>Suh</surname><given-names>J-K</given-names></name><name><surname>Ryu</surname><given-names>J-K</given-names></name><name><surname>Park</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Single-cell transcriptome analysis of cavernous tissues reveals the key roles of pericytes in diabetic erectile dysfunction</article-title><source>eLife</source><volume>12</volume><elocation-id>eRP88942</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.88942</pub-id><pub-id pub-id-type="pmid">38856719</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Battistini</surname><given-names>A</given-names></name><name><surname>Sgarbanti</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>HIV-1 latency: an update of molecular mechanisms and therapeutic strategies</article-title><source>Viruses</source><volume>6</volume><fpage>1715</fpage><lpage>1758</lpage><pub-id pub-id-type="doi">10.3390/v6041715</pub-id><pub-id pub-id-type="pmid">24736215</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bradley</surname><given-names>T</given-names></name><name><surname>Ferrari</surname><given-names>G</given-names></name><name><surname>Haynes</surname><given-names>BF</given-names></name><name><surname>Margolis</surname><given-names>DM</given-names></name><name><surname>Browne</surname><given-names>EP</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Single-cell analysis of quiescent HIV infection reveals host transcriptional profiles that regulate proviral latency</article-title><source>Cell Reports</source><volume>25</volume><fpage>107</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.09.020</pub-id><pub-id pub-id-type="pmid">30282021</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruner</surname><given-names>KM</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Simonetti</surname><given-names>FR</given-names></name><name><surname>Bender</surname><given-names>AM</given-names></name><name><surname>Kwon</surname><given-names>KJ</given-names></name><name><surname>Sengupta</surname><given-names>S</given-names></name><name><surname>Fray</surname><given-names>EJ</given-names></name><name><surname>Beg</surname><given-names>SA</given-names></name><name><surname>Antar</surname><given-names>AAR</given-names></name><name><surname>Jenike</surname><given-names>KM</given-names></name><name><surname>Bertagnolli</surname><given-names>LN</given-names></name><name><surname>Capoferri</surname><given-names>AA</given-names></name><name><surname>Kufera</surname><given-names>JT</given-names></name><name><surname>Timmons</surname><given-names>A</given-names></name><name><surname>Nobles</surname><given-names>C</given-names></name><name><surname>Gregg</surname><given-names>J</given-names></name><name><surname>Wada</surname><given-names>N</given-names></name><name><surname>Ho</surname><given-names>Y-C</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Margolick</surname><given-names>JB</given-names></name><name><surname>Blankson</surname><given-names>JN</given-names></name><name><surname>Deeks</surname><given-names>SG</given-names></name><name><surname>Bushman</surname><given-names>FD</given-names></name><name><surname>Siliciano</surname><given-names>JD</given-names></name><name><surname>Laird</surname><given-names>GM</given-names></name><name><surname>Siliciano</surname><given-names>RF</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A quantitative approach for measuring the reservoir of latent HIV-1 proviruses</article-title><source>Nature</source><volume>566</volume><fpage>120</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-0898-8</pub-id><pub-id pub-id-type="pmid">30700913</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castro</surname><given-names>G</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Ngo</surname><given-names>K</given-names></name><name><surname>De Leon-Tabaldo</surname><given-names>A</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Luna-Roman</surname><given-names>R</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Cao</surname><given-names>T</given-names></name><name><surname>Kuhn</surname><given-names>R</given-names></name><name><surname>Wilkinson</surname><given-names>P</given-names></name><name><surname>Herman</surname><given-names>K</given-names></name><name><surname>Nelen</surname><given-names>MI</given-names></name><name><surname>Blevitt</surname><given-names>J</given-names></name><name><surname>Xue</surname><given-names>X</given-names></name><name><surname>Fourie</surname><given-names>A</given-names></name><name><surname>Fung-Leung</surname><given-names>W-P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>RORÎ³t and RORÎ± signature genes in human Th17 cells</article-title><source>PLOS ONE</source><volume>12</volume><elocation-id>e0181868</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0181868</pub-id><pub-id pub-id-type="pmid">28763457</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Zhong</surname><given-names>H</given-names></name><name><surname>Hu</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Lin</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Xu</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Cai</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Transcriptome analysis of CD4<sup>+</sup> T cells from HIV-infected individuals receiving ART with LLV revealed novel transcription factors regulating HIV-1 promoter activity</article-title><source>Virologica Sinica</source><volume>38</volume><fpage>398</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1016/j.virs.2023.03.001</pub-id><pub-id pub-id-type="pmid">36907331</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coiras</surname><given-names>M</given-names></name><name><surname>LÃ³pez-Huertas</surname><given-names>MR</given-names></name><name><surname>Rullas</surname><given-names>J</given-names></name><name><surname>Mittelbrunn</surname><given-names>M</given-names></name><name><surname>AlcamÃ­</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Basal shuttle of NF-kappaB/I kappaB alpha in resting T lymphocytes regulates HIV-1 LTR dependent expression</article-title><source>Retrovirology</source><volume>4</volume><elocation-id>56</elocation-id><pub-id pub-id-type="doi">10.1186/1742-4690-4-56</pub-id><pub-id pub-id-type="pmid">17686171</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collora</surname><given-names>JA</given-names></name><name><surname>Liu</surname><given-names>R</given-names></name><name><surname>Pinto-Santini</surname><given-names>D</given-names></name><name><surname>Ravindra</surname><given-names>N</given-names></name><name><surname>Ganoza</surname><given-names>C</given-names></name><name><surname>Lama</surname><given-names>JR</given-names></name><name><surname>Alfaro</surname><given-names>R</given-names></name><name><surname>Chiarella</surname><given-names>J</given-names></name><name><surname>Spudich</surname><given-names>S</given-names></name><name><surname>Mounzer</surname><given-names>K</given-names></name><name><surname>Tebas</surname><given-names>P</given-names></name><name><surname>Montaner</surname><given-names>LJ</given-names></name><name><surname>van Dijk</surname><given-names>D</given-names></name><name><surname>Duerr</surname><given-names>A</given-names></name><name><surname>Ho</surname><given-names>Y-C</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Single-cell multiomics reveals persistence of HIV-1 in expanded cytotoxic T cell clones</article-title><source>Immunity</source><volume>55</volume><fpage>1013</fpage><lpage>1031</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2022.03.004</pub-id><pub-id pub-id-type="pmid">35320704</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cousin</surname><given-names>C</given-names></name><name><surname>Aubatin</surname><given-names>A</given-names></name><name><surname>Le Gouvello</surname><given-names>S</given-names></name><name><surname>Apetoh</surname><given-names>L</given-names></name><name><surname>Castellano</surname><given-names>F</given-names></name><name><surname>Molinier-Frenkel</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The immunosuppressive enzyme IL4I1 promotes FoxP3(+) regulatory T lymphocyte differentiation</article-title><source>European Journal of Immunology</source><volume>45</volume><fpage>1772</fpage><lpage>1782</lpage><pub-id pub-id-type="doi">10.1002/eji.201445000</pub-id><pub-id pub-id-type="pmid">25778793</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deeks</surname><given-names>SG</given-names></name><name><surname>Overbaugh</surname><given-names>J</given-names></name><name><surname>Phillips</surname><given-names>A</given-names></name><name><surname>Buchbinder</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>HIV infection</article-title><source>Nature Reviews. Disease Primers</source><volume>1</volume><elocation-id>e15035</elocation-id><pub-id pub-id-type="doi">10.1038/nrdp.2015.35</pub-id><pub-id pub-id-type="pmid">27188527</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Didichenko</surname><given-names>SA</given-names></name><name><surname>Spiegl</surname><given-names>N</given-names></name><name><surname>Brunner</surname><given-names>T</given-names></name><name><surname>Dahinden</surname><given-names>CA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>IL-3 induces a Pim1-dependent antiapoptotic pathway in primary human basophils</article-title><source>Blood</source><volume>112</volume><fpage>3949</fpage><lpage>3958</lpage><pub-id pub-id-type="doi">10.1182/blood-2008-04-149419</pub-id><pub-id pub-id-type="pmid">18768389</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Douek</surname><given-names>DC</given-names></name><name><surname>Brenchley</surname><given-names>JM</given-names></name><name><surname>Betts</surname><given-names>MR</given-names></name><name><surname>Ambrozak</surname><given-names>DR</given-names></name><name><surname>Hill</surname><given-names>BJ</given-names></name><name><surname>Okamoto</surname><given-names>Y</given-names></name><name><surname>Casazza</surname><given-names>JP</given-names></name><name><surname>Kuruppu</surname><given-names>J</given-names></name><name><surname>Kunstman</surname><given-names>K</given-names></name><name><surname>Wolinsky</surname><given-names>S</given-names></name><name><surname>Grossman</surname><given-names>Z</given-names></name><name><surname>Dybul</surname><given-names>M</given-names></name><name><surname>Oxenius</surname><given-names>A</given-names></name><name><surname>Price</surname><given-names>DA</given-names></name><name><surname>Connors</surname><given-names>M</given-names></name><name><surname>Koup</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>HIV preferentially infects HIV-specific CD4+ T cells</article-title><source>Nature</source><volume>417</volume><fpage>95</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1038/417095a</pub-id><pub-id pub-id-type="pmid">11986671</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Douek</surname><given-names>DC</given-names></name><name><surname>Picker</surname><given-names>LJ</given-names></name><name><surname>Koup</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>T cell dynamics in HIV-1 infection</article-title><source>Annual Review of Immunology</source><volume>21</volume><fpage>265</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1146/annurev.immunol.21.120601.141053</pub-id><pub-id pub-id-type="pmid">12524385</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duverger</surname><given-names>A</given-names></name><name><surname>Wolschendorf</surname><given-names>F</given-names></name><name><surname>Anderson</surname><given-names>JC</given-names></name><name><surname>Wagner</surname><given-names>F</given-names></name><name><surname>Bosque</surname><given-names>A</given-names></name><name><surname>Shishido</surname><given-names>T</given-names></name><name><surname>Jones</surname><given-names>J</given-names></name><name><surname>Planelles</surname><given-names>V</given-names></name><name><surname>Willey</surname><given-names>C</given-names></name><name><surname>Cron</surname><given-names>RQ</given-names></name><name><surname>Kutsch</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Kinase control of latent HIV-1 infection: PIM-1 kinase as a major contributor to HIV-1 reactivation</article-title><source>Journal of Virology</source><volume>88</volume><fpage>364</fpage><lpage>376</lpage><pub-id pub-id-type="doi">10.1128/JVI.02682-13</pub-id><pub-id pub-id-type="pmid">24155393</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Efremova</surname><given-names>M</given-names></name><name><surname>Vento-Tormo</surname><given-names>M</given-names></name><name><surname>Teichmann</surname><given-names>SA</given-names></name><name><surname>Vento-Tormo</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes</article-title><source>Nature Protocols</source><volume>15</volume><fpage>1484</fpage><lpage>1506</lpage><pub-id pub-id-type="doi">10.1038/s41596-020-0292-x</pub-id><pub-id pub-id-type="pmid">32103204</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eun</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Shin</surname><given-names>S-I</given-names></name><name><surname>Yang</surname><given-names>HO</given-names></name><name><surname>Kim</surname><given-names>K-D</given-names></name><name><surname>Choi</surname><given-names>SY</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>DK</given-names></name><name><surname>Jeong</surname><given-names>CW</given-names></name><name><surname>Moon</surname><given-names>KC</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Park</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Chromatin accessibility analysis and architectural profiling of human kidneys reveal key cell types and a regulator of diabetic kidney disease</article-title><source>Kidney International</source><volume>105</volume><fpage>150</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1016/j.kint.2023.09.030</pub-id><pub-id pub-id-type="pmid">37925023</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiebig</surname><given-names>EW</given-names></name><name><surname>Wright</surname><given-names>DJ</given-names></name><name><surname>Rawal</surname><given-names>BD</given-names></name><name><surname>Garrett</surname><given-names>PE</given-names></name><name><surname>Schumacher</surname><given-names>RT</given-names></name><name><surname>Peddada</surname><given-names>L</given-names></name><name><surname>Heldebrant</surname><given-names>C</given-names></name><name><surname>Smith</surname><given-names>R</given-names></name><name><surname>Conrad</surname><given-names>A</given-names></name><name><surname>Kleinman</surname><given-names>SH</given-names></name><name><surname>Busch</surname><given-names>MP</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection</article-title><source>AIDS</source><volume>17</volume><fpage>1871</fpage><lpage>1879</lpage><pub-id pub-id-type="doi">10.1097/00002030-200309050-00005</pub-id><pub-id pub-id-type="pmid">12960819</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geretz</surname><given-names>A</given-names></name><name><surname>Ehrenberg</surname><given-names>PK</given-names></name><name><surname>Clifford</surname><given-names>RJ</given-names></name><name><surname>LalibertÃ©</surname><given-names>A</given-names></name><name><surname>Prelli Bozzo</surname><given-names>C</given-names></name><name><surname>Eiser</surname><given-names>D</given-names></name><name><surname>Kundu</surname><given-names>G</given-names></name><name><surname>Yum</surname><given-names>LK</given-names></name><name><surname>Apps</surname><given-names>R</given-names></name><name><surname>Creegan</surname><given-names>M</given-names></name><name><surname>Gunady</surname><given-names>M</given-names></name><name><surname>Shangguan</surname><given-names>S</given-names></name><name><surname>Sanders-Buell</surname><given-names>E</given-names></name><name><surname>Sacdalan</surname><given-names>C</given-names></name><name><surname>Phanuphak</surname><given-names>N</given-names></name><name><surname>Tovanabutra</surname><given-names>S</given-names></name><name><surname>Russell</surname><given-names>RM</given-names></name><name><surname>Bibollet-Ruche</surname><given-names>F</given-names></name><name><surname>Robb</surname><given-names>ML</given-names></name><name><surname>Michael</surname><given-names>NL</given-names></name><name><surname>Ake</surname><given-names>JA</given-names></name><name><surname>Vasan</surname><given-names>S</given-names></name><name><surname>Hsu</surname><given-names>DC</given-names></name><name><surname>Hahn</surname><given-names>BH</given-names></name><name><surname>Kirchhoff</surname><given-names>F</given-names></name><name><surname>Thomas</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Single-cell transcriptomics identifies prothymosin Î± restriction of HIV-1 in vivo</article-title><source>Science Translational Medicine</source><volume>15</volume><elocation-id>eadg0873</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.adg0873</pub-id><pub-id pub-id-type="pmid">37531416</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golumbeanu</surname><given-names>M</given-names></name><name><surname>Cristinelli</surname><given-names>S</given-names></name><name><surname>Rato</surname><given-names>S</given-names></name><name><surname>Munoz</surname><given-names>M</given-names></name><name><surname>Cavassini</surname><given-names>M</given-names></name><name><surname>Beerenwinkel</surname><given-names>N</given-names></name><name><surname>Ciuffi</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Single-cell RNA-seq reveals transcriptional heterogeneity in latent and reactivated HIV-infected cells</article-title><source>Cell Reports</source><volume>23</volume><fpage>942</fpage><lpage>950</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.03.102</pub-id><pub-id pub-id-type="pmid">29694901</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gouwy</surname><given-names>M</given-names></name><name><surname>Struyf</surname><given-names>S</given-names></name><name><surname>Berghmans</surname><given-names>N</given-names></name><name><surname>Vanormelingen</surname><given-names>C</given-names></name><name><surname>Schols</surname><given-names>D</given-names></name><name><surname>Van Damme</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>CXCR4 and CCR5 ligands cooperate in monocyte and lymphocyte migration and in inhibition of dual-tropic (R5/X4) HIV-1 infection</article-title><source>European Journal of Immunology</source><volume>41</volume><fpage>963</fpage><lpage>973</lpage><pub-id pub-id-type="doi">10.1002/eji.201041178</pub-id><pub-id pub-id-type="pmid">21381021</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gulzar</surname><given-names>N</given-names></name><name><surname>Copeland</surname><given-names>KFT</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>CD8+ T-cells: function and response to HIV infection</article-title><source>Current HIV Research</source><volume>2</volume><fpage>23</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.2174/1570162043485077</pub-id><pub-id pub-id-type="pmid">15053338</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hart</surname><given-names>GT</given-names></name><name><surname>Hogquist</surname><given-names>KA</given-names></name><name><surname>Jameson</surname><given-names>SC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>KrÃ¼ppel-like factors in lymphocyte biology</article-title><source>Journal of Immunology</source><volume>188</volume><fpage>521</fpage><lpage>526</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1101530</pub-id><pub-id pub-id-type="pmid">22223851</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heumos</surname><given-names>L</given-names></name><name><surname>Schaar</surname><given-names>AC</given-names></name><name><surname>Lance</surname><given-names>C</given-names></name><name><surname>Litinetskaya</surname><given-names>A</given-names></name><name><surname>Drost</surname><given-names>F</given-names></name><name><surname>Zappia</surname><given-names>L</given-names></name><name><surname>LÃ¼cken</surname><given-names>MD</given-names></name><name><surname>Strobl</surname><given-names>DC</given-names></name><name><surname>Henao</surname><given-names>J</given-names></name><name><surname>Curion</surname><given-names>F</given-names></name><collab>Single-cell Best Practices Consortium</collab><name><surname>Schiller</surname><given-names>HB</given-names></name><name><surname>Theis</surname><given-names>FJ</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Best practices for single-cell analysis across modalities</article-title><source>Nature Reviews. Genetics</source><volume>24</volume><fpage>550</fpage><lpage>572</lpage><pub-id pub-id-type="doi">10.1038/s41576-023-00586-w</pub-id><pub-id pub-id-type="pmid">37002403</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>Y-C</given-names></name><name><surname>Shan</surname><given-names>L</given-names></name><name><surname>Hosmane</surname><given-names>NN</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Laskey</surname><given-names>SB</given-names></name><name><surname>Rosenbloom</surname><given-names>DIS</given-names></name><name><surname>Lai</surname><given-names>J</given-names></name><name><surname>Blankson</surname><given-names>JN</given-names></name><name><surname>Siliciano</surname><given-names>JD</given-names></name><name><surname>Siliciano</surname><given-names>RF</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure</article-title><source>Cell</source><volume>155</volume><fpage>540</fpage><lpage>551</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.09.020</pub-id><pub-id pub-id-type="pmid">24243014</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horsburgh</surname><given-names>BA</given-names></name><name><surname>Hiener</surname><given-names>B</given-names></name><name><surname>Fisher</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>E</given-names></name><name><surname>Morgan</surname><given-names>H</given-names></name><name><surname>Eden</surname><given-names>J-S</given-names></name><name><surname>von Stockenstrom</surname><given-names>S</given-names></name><name><surname>Odevall</surname><given-names>L</given-names></name><name><surname>Milush</surname><given-names>JM</given-names></name><name><surname>Hoh</surname><given-names>R</given-names></name><name><surname>Fromentin</surname><given-names>R</given-names></name><name><surname>Chomont</surname><given-names>N</given-names></name><name><surname>Hecht</surname><given-names>FM</given-names></name><name><surname>Schlub</surname><given-names>TE</given-names></name><name><surname>Deeks</surname><given-names>SG</given-names></name><name><surname>Palmer</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Cellular activation, differentiation, and proliferation influence the dynamics of genetically intact proviruses over time</article-title><source>The Journal of Infectious Diseases</source><volume>225</volume><fpage>1168</fpage><lpage>1178</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiab291</pub-id><pub-id pub-id-type="pmid">34037766</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>HÃ¼tter</surname><given-names>G</given-names></name><name><surname>Nowak</surname><given-names>D</given-names></name><name><surname>Mossner</surname><given-names>M</given-names></name><name><surname>Ganepola</surname><given-names>S</given-names></name><name><surname>MÃ¼ssig</surname><given-names>A</given-names></name><name><surname>Allers</surname><given-names>K</given-names></name><name><surname>Schneider</surname><given-names>T</given-names></name><name><surname>Hofmann</surname><given-names>J</given-names></name><name><surname>KÃ¼cherer</surname><given-names>C</given-names></name><name><surname>Blau</surname><given-names>O</given-names></name><name><surname>Blau</surname><given-names>IW</given-names></name><name><surname>Hofmann</surname><given-names>WK</given-names></name><name><surname>Thiel</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation</article-title><source>The New England Journal of Medicine</source><volume>360</volume><fpage>692</fpage><lpage>698</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa0802905</pub-id><pub-id pub-id-type="pmid">19213682</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiao</surname><given-names>Y</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Higher HIV DNA in CD4+ naÃ¯ve T-cells during acute HIV-1 infection in rapid progressors</article-title><source>Viral Immunology</source><volume>27</volume><fpage>316</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.1089/vim.2014.0037</pub-id><pub-id pub-id-type="pmid">24892927</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>S</given-names></name><name><surname>Plikus</surname><given-names>MV</given-names></name><name><surname>Nie</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2025">2025</year><article-title>CellChat for systematic analysis of cell-cell communication from single-cell transcriptomics</article-title><source>Nature Protocols</source><volume>20</volume><fpage>180</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1038/s41596-024-01045-4</pub-id><pub-id pub-id-type="pmid">39289562</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katze</surname><given-names>MG</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Gale</surname><given-names>M</given-names><suffix>Jr</suffix></name></person-group><year iso-8601-date="2002">2002</year><article-title>Viruses and interferon: a fight for supremacy</article-title><source>Nature Reviews. Immunology</source><volume>2</volume><fpage>675</fpage><lpage>687</lpage><pub-id pub-id-type="doi">10.1038/nri888</pub-id><pub-id pub-id-type="pmid">12209136</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kazer</surname><given-names>SW</given-names></name><name><surname>Aicher</surname><given-names>TP</given-names></name><name><surname>Muema</surname><given-names>DM</given-names></name><name><surname>Carroll</surname><given-names>SL</given-names></name><name><surname>Ordovas-Montanes</surname><given-names>J</given-names></name><name><surname>Miao</surname><given-names>VN</given-names></name><name><surname>Tu</surname><given-names>AA</given-names></name><name><surname>Ziegler</surname><given-names>CGK</given-names></name><name><surname>Nyquist</surname><given-names>SK</given-names></name><name><surname>Wong</surname><given-names>EB</given-names></name><name><surname>Ismail</surname><given-names>N</given-names></name><name><surname>Dong</surname><given-names>M</given-names></name><name><surname>Moodley</surname><given-names>A</given-names></name><name><surname>Berger</surname><given-names>B</given-names></name><name><surname>Love</surname><given-names>JC</given-names></name><name><surname>Dong</surname><given-names>KL</given-names></name><name><surname>Leslie</surname><given-names>A</given-names></name><name><surname>Ndhlovu</surname><given-names>ZM</given-names></name><name><surname>Ndungâu</surname><given-names>T</given-names></name><name><surname>Walker</surname><given-names>BD</given-names></name><name><surname>Shalek</surname><given-names>AK</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Integrated single-cell analysis of multicellular immune dynamics during hyperacute HIV-1 infection</article-title><source>Nature Medicine</source><volume>26</volume><fpage>511</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.1038/s41591-020-0799-2</pub-id><pub-id pub-id-type="pmid">32251406</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Single-cell transcriptomics: a novel precision medicine technique in nephrology</article-title><source>The Korean Journal of Internal Medicine</source><volume>36</volume><fpage>479</fpage><lpage>490</lpage><pub-id pub-id-type="doi">10.3904/kjim.2020.415</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>GD</given-names></name><name><surname>Lim</surname><given-names>C</given-names></name><name><surname>Park</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2024">2024a</year><article-title>A practical handbook on single-cell RNA sequencing data quality control and downstream analysis</article-title><source>Molecules and Cells</source><volume>47</volume><elocation-id>100103</elocation-id><pub-id pub-id-type="doi">10.1016/j.mocell.2024.100103</pub-id><pub-id pub-id-type="pmid">39094968</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>GD</given-names></name><name><surname>Shin</surname><given-names>S-I</given-names></name><name><surname>Jung</surname><given-names>SW</given-names></name><name><surname>An</surname><given-names>H</given-names></name><name><surname>Choi</surname><given-names>SY</given-names></name><name><surname>Eun</surname><given-names>M</given-names></name><name><surname>Jun</surname><given-names>C-D</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2024">2024b</year><article-title>Cell type- and age-specific expression of lncRNAs across kidney cell types</article-title><source>Journal of the American Society of Nephrology</source><volume>35</volume><fpage>870</fpage><lpage>885</lpage><pub-id pub-id-type="doi">10.1681/ASN.0000000000000354</pub-id><pub-id pub-id-type="pmid">38621182</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korsunsky</surname><given-names>I</given-names></name><name><surname>Millard</surname><given-names>N</given-names></name><name><surname>Fan</surname><given-names>J</given-names></name><name><surname>Slowikowski</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Wei</surname><given-names>K</given-names></name><name><surname>Baglaenko</surname><given-names>Y</given-names></name><name><surname>Brenner</surname><given-names>M</given-names></name><name><surname>Loh</surname><given-names>P-R</given-names></name><name><surname>Raychaudhuri</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Fast, sensitive and accurate integration of single-cell data with Harmony</article-title><source>Nature Methods</source><volume>16</volume><fpage>1289</fpage><lpage>1296</lpage><pub-id pub-id-type="doi">10.1038/s41592-019-0619-0</pub-id><pub-id pub-id-type="pmid">31740819</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuo</surname><given-names>CT</given-names></name><name><surname>Veselits</surname><given-names>ML</given-names></name><name><surname>Leiden</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>LKLF: A transcriptional regulator of single-positive T cell quiescence and survival</article-title><source>Science</source><volume>277</volume><fpage>1986</fpage><lpage>1990</lpage><pub-id pub-id-type="doi">10.1126/science.277.5334.1986</pub-id><pub-id pub-id-type="pmid">9302292</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lange</surname><given-names>UC</given-names></name><name><surname>Verdikt</surname><given-names>R</given-names></name><name><surname>Ait-Ammar</surname><given-names>A</given-names></name><name><surname>Van Lint</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Epigenetic crosstalk in chronic infection with HIV-1</article-title><source>Seminars in Immunopathology</source><volume>42</volume><fpage>187</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1007/s00281-020-00783-3</pub-id><pub-id pub-id-type="pmid">32047948</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>D</given-names></name><name><surname>Yoon</surname><given-names>C-H</given-names></name><name><surname>Choi</surname><given-names>SY</given-names></name><name><surname>Kim</surname><given-names>J-E</given-names></name><name><surname>Cho</surname><given-names>Y-K</given-names></name><name><surname>Choi</surname><given-names>B-S</given-names></name><name><surname>Park</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Transcriptome analysis identifies altered biological processes and novel markers in human immunodeficiency virus-1 long-term non-progressors</article-title><source>Infection &amp; Chemotherapy</source><volume>53</volume><fpage>489</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.3947/ic.2021.0031</pub-id><pub-id pub-id-type="pmid">34623779</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>R</given-names></name><name><surname>Yeh</surname><given-names>YHJ</given-names></name><name><surname>Varabyou</surname><given-names>A</given-names></name><name><surname>Collora</surname><given-names>JA</given-names></name><name><surname>Sherrill-Mix</surname><given-names>S</given-names></name><name><surname>Talbot</surname><given-names>CC</given-names></name><name><surname>Mehta</surname><given-names>S</given-names></name><name><surname>Albrecht</surname><given-names>K</given-names></name><name><surname>Hao</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Pollack</surname><given-names>RA</given-names></name><name><surname>Beg</surname><given-names>SA</given-names></name><name><surname>Calvi</surname><given-names>RM</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Durand</surname><given-names>CM</given-names></name><name><surname>Ambinder</surname><given-names>RF</given-names></name><name><surname>Hoh</surname><given-names>R</given-names></name><name><surname>Deeks</surname><given-names>SG</given-names></name><name><surname>Chiarella</surname><given-names>J</given-names></name><name><surname>Spudich</surname><given-names>S</given-names></name><name><surname>Douek</surname><given-names>DC</given-names></name><name><surname>Bushman</surname><given-names>FD</given-names></name><name><surname>Pertea</surname><given-names>M</given-names></name><name><surname>Ho</surname><given-names>YC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell transcriptional landscapes reveal HIV-1-driven aberrant host gene transcription as a potential therapeutic target</article-title><source>Science Translational Medicine</source><volume>12</volume><elocation-id>eaaz0802</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.aaz0802</pub-id><pub-id pub-id-type="pmid">32404504</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Pan</surname><given-names>Q</given-names></name><name><surname>Rong</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>S-L</given-names></name><name><surname>Liang</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The IFITM proteins inhibit HIV-1 infection</article-title><source>Journal of Virology</source><volume>85</volume><fpage>2126</fpage><lpage>2137</lpage><pub-id pub-id-type="doi">10.1128/JVI.01531-10</pub-id><pub-id pub-id-type="pmid">21177806</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>H</given-names></name><name><surname>Xia</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>L-B</given-names></name><name><surname>An</surname><given-names>H</given-names></name><name><surname>Cao</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>GD</given-names></name><name><surname>Chen</surname><given-names>H-N</given-names></name><name><surname>Zhang</surname><given-names>W-H</given-names></name><name><surname>Shu</surname><given-names>Y</given-names></name><name><surname>Kong</surname><given-names>X</given-names></name><name><surname>Ren</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>P-H</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Bai</surname><given-names>B</given-names></name><name><surname>Jia</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Dai</surname><given-names>L</given-names></name><name><surname>Hu</surname><given-names>H</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Caulin</surname><given-names>C</given-names></name><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment</article-title><source>Nature Communications</source><volume>13</volume><elocation-id>6619</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-022-34395-2</pub-id><pub-id pub-id-type="pmid">36333338</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masenga</surname><given-names>SK</given-names></name><name><surname>Mweene</surname><given-names>BC</given-names></name><name><surname>Luwaya</surname><given-names>E</given-names></name><name><surname>Muchaili</surname><given-names>L</given-names></name><name><surname>Chona</surname><given-names>M</given-names></name><name><surname>Kirabo</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>HIV-Host Cell Interactions</article-title><source>Cells</source><volume>12</volume><elocation-id>e10</elocation-id><pub-id pub-id-type="doi">10.3390/cells12101351</pub-id><pub-id pub-id-type="pmid">37408185</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGinnis</surname><given-names>CS</given-names></name><name><surname>Murrow</surname><given-names>LM</given-names></name><name><surname>Gartner</surname><given-names>ZJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Doubletfinder: doublet detection in single-cell rna sequencing data using artificial nearest neighbors</article-title><source>Cell Systems</source><volume>8</volume><fpage>329</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1016/j.cels.2019.03.003</pub-id><pub-id pub-id-type="pmid">30954475</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mudd</surname><given-names>JC</given-names></name><name><surname>Lederman</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>CD8 T cell persistence in treated HIV infection</article-title><source>Current Opinion in HIV and AIDS</source><volume>9</volume><fpage>500</fpage><lpage>505</lpage><pub-id pub-id-type="doi">10.1097/COH.0000000000000086</pub-id><pub-id pub-id-type="pmid">25010897</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muri</surname><given-names>J</given-names></name><name><surname>Thut</surname><given-names>H</given-names></name><name><surname>Kopf</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The thioredoxin-1 inhibitor Txnip restrains effector T-cell and germinal center B-cell expansion</article-title><source>European Journal of Immunology</source><volume>51</volume><fpage>115</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1002/eji.202048851</pub-id><pub-id pub-id-type="pmid">32902872</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pantaleo</surname><given-names>G</given-names></name><name><surname>Graziosi</surname><given-names>C</given-names></name><name><surname>Fauci</surname><given-names>AS</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>The role of lymphoid organs in the pathogenesis of HIV infection</article-title><source>Seminars in Immunology</source><volume>5</volume><fpage>157</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1006/smim.1993.1019</pub-id><pub-id pub-id-type="pmid">8102261</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Lim</surname><given-names>CH</given-names></name><name><surname>Ham</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>SS</given-names></name><name><surname>Choi</surname><given-names>B-S</given-names></name><name><surname>Roh</surname><given-names>T-Y</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Genome-wide analysis of histone modifications in latently HIV-1 infected T cells</article-title><source>AIDS</source><volume>28</volume><fpage>1719</fpage><lpage>1728</lpage><pub-id pub-id-type="doi">10.1097/QAD.0000000000000309</pub-id><pub-id pub-id-type="pmid">24762674</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parker</surname><given-names>E</given-names></name><name><surname>Judge</surname><given-names>MA</given-names></name><name><surname>Pastor</surname><given-names>L</given-names></name><name><surname>Fuente-Soro</surname><given-names>L</given-names></name><name><surname>Jairoce</surname><given-names>C</given-names></name><name><surname>Carter</surname><given-names>KW</given-names></name><name><surname>Anderson</surname><given-names>D</given-names></name><name><surname>Mandomando</surname><given-names>I</given-names></name><name><surname>Clifford</surname><given-names>HD</given-names></name><name><surname>Naniche</surname><given-names>D</given-names></name><name><surname>Le SouÃ«f</surname><given-names>PN</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Gene dysregulation in acute HIV-1 infection - early transcriptomic analysis reveals the crucial biological functions affected</article-title><source>Frontiers in Cellular and Infection Microbiology</source><volume>13</volume><elocation-id>e1074847</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2023.1074847</pub-id><pub-id pub-id-type="pmid">37077524</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pedro</surname><given-names>KD</given-names></name><name><surname>Agosto</surname><given-names>LM</given-names></name><name><surname>Sewell</surname><given-names>JA</given-names></name><name><surname>Eberenz</surname><given-names>KA</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Fuxman Bass</surname><given-names>JI</given-names></name><name><surname>Henderson</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A functional screen identifies transcriptional networks that regulate HIV-1 and HIV-2</article-title><source>PNAS</source><volume>118</volume><elocation-id>e2012835118</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2012835118</pub-id><pub-id pub-id-type="pmid">33836568</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Permanyer</surname><given-names>M</given-names></name><name><surname>Ballana</surname><given-names>E</given-names></name><name><surname>Ruiz</surname><given-names>A</given-names></name><name><surname>Badia</surname><given-names>R</given-names></name><name><surname>Riveira-Munoz</surname><given-names>E</given-names></name><name><surname>Gonzalo</surname><given-names>E</given-names></name><name><surname>Clotet</surname><given-names>B</given-names></name><name><surname>EstÃ©</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Antiretroviral agents effectively block HIV replication after cell-to-cell transfer</article-title><source>Journal of Virology</source><volume>86</volume><fpage>8773</fpage><lpage>8780</lpage><pub-id pub-id-type="doi">10.1128/JVI.01044-12</pub-id><pub-id pub-id-type="pmid">22696642</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Pestal</surname><given-names>K</given-names></name><name><surname>Slayden</surname><given-names>LC</given-names></name><name><surname>Barton</surname><given-names>GM</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>KrÃ¼ppel-like Factor (KLF) Family Members Control Expression of Genes Required for Serous Cavity and Alveolar Macrophage Identities</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2024.02.28.582578</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>TE</given-names></name><name><surname>Baker</surname><given-names>JV</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Assessing inflammation and its role in comorbidities among persons living with HIV</article-title><source>Current Opinion in Infectious Diseases</source><volume>32</volume><fpage>8</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1097/QCO.0000000000000510</pub-id><pub-id pub-id-type="pmid">30461454</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richardson</surname><given-names>MW</given-names></name><name><surname>Jadlowsky</surname><given-names>J</given-names></name><name><surname>Didigu</surname><given-names>CA</given-names></name><name><surname>Doms</surname><given-names>RW</given-names></name><name><surname>Riley</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Kruppel-like factor 2 modulates CCR5 expression and susceptibility to HIV-1 infection</article-title><source>Journal of Immunology</source><volume>189</volume><fpage>3815</fpage><lpage>3821</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1201431</pub-id><pub-id pub-id-type="pmid">22988032</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>S</given-names></name><name><surname>Bag</surname><given-names>AK</given-names></name><name><surname>Singh</surname><given-names>RK</given-names></name><name><surname>Talmadge</surname><given-names>JE</given-names></name><name><surname>Batra</surname><given-names>SK</given-names></name><name><surname>Datta</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Multifaceted role of Neuropilins in the immune system: Potential targets for immunotherapy</article-title><source>Frontiers in Immunology</source><volume>8</volume><elocation-id>e1228</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2017.01228</pub-id><pub-id pub-id-type="pmid">29067024</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satarker</surname><given-names>S</given-names></name><name><surname>Tom</surname><given-names>AA</given-names></name><name><surname>Shaji</surname><given-names>RA</given-names></name><name><surname>Alosious</surname><given-names>A</given-names></name><name><surname>Luvis</surname><given-names>M</given-names></name><name><surname>Nampoothiri</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>JAK-STAT pathway inhibition and their implications in COVID-19 therapy</article-title><source>Postgraduate Medicine</source><volume>133</volume><fpage>489</fpage><lpage>507</lpage><pub-id pub-id-type="doi">10.1080/00325481.2020.1855921</pub-id><pub-id pub-id-type="pmid">33245005</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schep</surname><given-names>AN</given-names></name><name><surname>Wu</surname><given-names>B</given-names></name><name><surname>Buenrostro</surname><given-names>JD</given-names></name><name><surname>Greenleaf</surname><given-names>WJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>chromVAR: inferring transcription-factor-associated accessibility from single-cell epigenomic data</article-title><source>Nature Methods</source><volume>14</volume><fpage>975</fpage><lpage>978</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4401</pub-id><pub-id pub-id-type="pmid">28825706</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>SenBanerjee</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>Z</given-names></name><name><surname>Atkins</surname><given-names>GB</given-names></name><name><surname>Greif</surname><given-names>DM</given-names></name><name><surname>Rao</surname><given-names>RM</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Feinberg</surname><given-names>MW</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Simon</surname><given-names>DI</given-names></name><name><surname>Luscinskas</surname><given-names>FW</given-names></name><name><surname>Michel</surname><given-names>TM</given-names></name><name><surname>Gimbrone</surname><given-names>MA</given-names><suffix>Jr</suffix></name><name><surname>GarcÃ­a-CardeÃ±a</surname><given-names>G</given-names></name><name><surname>Jain</surname><given-names>MK</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation</article-title><source>The Journal of Experimental Medicine</source><volume>199</volume><fpage>1305</fpage><lpage>1315</lpage><pub-id pub-id-type="doi">10.1084/jem.20031132</pub-id><pub-id pub-id-type="pmid">15136591</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sreeram</surname><given-names>S</given-names></name><name><surname>Ye</surname><given-names>F</given-names></name><name><surname>Garcia-Mesa</surname><given-names>Y</given-names></name><name><surname>Nguyen</surname><given-names>K</given-names></name><name><surname>El Sayed</surname><given-names>A</given-names></name><name><surname>Leskov</surname><given-names>K</given-names></name><name><surname>Karn</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The potential role of HIV-1 latency in promoting neuroinflammation and HIV-1-associated neurocognitive disorder</article-title><source>Trends in Immunology</source><volume>43</volume><fpage>630</fpage><lpage>639</lpage><pub-id pub-id-type="doi">10.1016/j.it.2022.06.003</pub-id><pub-id pub-id-type="pmid">35840529</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuart</surname><given-names>T</given-names></name><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Hoffman</surname><given-names>P</given-names></name><name><surname>Hafemeister</surname><given-names>C</given-names></name><name><surname>Papalexi</surname><given-names>E</given-names></name><name><surname>Mauck</surname><given-names>WM</given-names></name><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Stoeckius</surname><given-names>M</given-names></name><name><surname>Smibert</surname><given-names>P</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Comprehensive integration of single-cell data</article-title><source>Cell</source><volume>177</volume><fpage>1888</fpage><lpage>1902</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.05.031</pub-id><pub-id pub-id-type="pmid">31178118</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuart</surname><given-names>T</given-names></name><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Madad</surname><given-names>S</given-names></name><name><surname>Lareau</surname><given-names>CA</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Single-cell chromatin state analysis with Signac</article-title><source>Nature Methods</source><volume>18</volume><fpage>1333</fpage><lpage>1341</lpage><pub-id pub-id-type="doi">10.1038/s41592-021-01282-5</pub-id><pub-id pub-id-type="pmid">34725479</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>W</given-names></name><name><surname>Gao</surname><given-names>C</given-names></name><name><surname>Hartana</surname><given-names>CA</given-names></name><name><surname>Osborn</surname><given-names>MR</given-names></name><name><surname>Einkauf</surname><given-names>KB</given-names></name><name><surname>Lian</surname><given-names>X</given-names></name><name><surname>Bone</surname><given-names>B</given-names></name><name><surname>Bonheur</surname><given-names>N</given-names></name><name><surname>Chun</surname><given-names>TW</given-names></name><name><surname>Rosenberg</surname><given-names>ES</given-names></name><name><surname>Walker</surname><given-names>BD</given-names></name><name><surname>Yu</surname><given-names>XG</given-names></name><name><surname>Lichterfeld</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Phenotypic signatures of immune selection in HIV-1 reservoir cells</article-title><source>Nature</source><volume>614</volume><fpage>309</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1038/s41586-022-05538-8</pub-id><pub-id pub-id-type="pmid">36599977</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takada</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Hart</surname><given-names>GT</given-names></name><name><surname>Odumade</surname><given-names>OA</given-names></name><name><surname>Weinreich</surname><given-names>MA</given-names></name><name><surname>Hogquist</surname><given-names>KA</given-names></name><name><surname>Jameson</surname><given-names>SC</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Kruppel-like factor 2 is required for trafficking but not quiescence in postactivated T cells</article-title><source>Journal of Immunology</source><volume>186</volume><fpage>775</fpage><lpage>783</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1000094</pub-id><pub-id pub-id-type="pmid">21160050</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uchil</surname><given-names>PD</given-names></name><name><surname>Quinlan</surname><given-names>BD</given-names></name><name><surname>Chan</surname><given-names>W-T</given-names></name><name><surname>Luna</surname><given-names>JM</given-names></name><name><surname>Mothes</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>TRIM E3 ligases interfere with early and late stages of the retroviral life cycle</article-title><source>PLOS Pathogens</source><volume>4</volume><elocation-id>e16</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.0040016</pub-id><pub-id pub-id-type="pmid">18248090</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verdikt</surname><given-names>R</given-names></name><name><surname>Hernalsteens</surname><given-names>O</given-names></name><name><surname>Van Lint</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Epigenetic mechanisms of HIV-1 persistence</article-title><source>Vaccines</source><volume>9</volume><elocation-id>514</elocation-id><pub-id pub-id-type="doi">10.3390/vaccines9050514</pub-id><pub-id pub-id-type="pmid">34067608</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Song</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>T</given-names></name><name><surname>Zeng</surname><given-names>C</given-names></name><name><surname>Jia</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2020">2020a</year><article-title>A computational study of TatâCDK9âCyclin binding dynamics and its implication in transcription-dependent HIV latency</article-title><source>Physical Chemistry Chemical Physics</source><volume>22</volume><fpage>25474</fpage><lpage>25482</lpage><pub-id pub-id-type="doi">10.1039/D0CP03662E</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Hui</surname><given-names>H</given-names></name><name><surname>Agrawal</surname><given-names>K</given-names></name><name><surname>Karris</surname><given-names>MAY</given-names></name><name><surname>Rana</surname><given-names>TM</given-names></name></person-group><year iso-8601-date="2020">2020b</year><article-title>An atlas of immune cell exhaustion in HIV-infected individuals revealed by single-cell transcriptomics</article-title><source>Emerging Microbes &amp; Infections</source><volume>9</volume><fpage>2333</fpage><lpage>2347</lpage><pub-id pub-id-type="doi">10.1080/22221751.2020.1826361</pub-id><pub-id pub-id-type="pmid">32954948</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Davenport</surname><given-names>TC</given-names></name><name><surname>Collora</surname><given-names>JA</given-names></name><name><surname>Ma</surname><given-names>HK</given-names></name><name><surname>Pinto-Santini</surname><given-names>D</given-names></name><name><surname>Lama</surname><given-names>J</given-names></name><name><surname>Alfaro</surname><given-names>R</given-names></name><name><surname>Duerr</surname><given-names>A</given-names></name><name><surname>Ho</surname><given-names>Y-C</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Single-cell epigenetic, transcriptional, and protein profiling of latent and active HIV-1 reservoir revealed that IKZF3 promotes HIV-1 persistence</article-title><source>Immunity</source><volume>56</volume><fpage>2584</fpage><lpage>2601</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2023.10.002</pub-id><pub-id pub-id-type="pmid">37922905</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Welte</surname><given-names>S</given-names></name><name><surname>Kuttruff</surname><given-names>S</given-names></name><name><surname>Waldhauer</surname><given-names>I</given-names></name><name><surname>Steinle</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction</article-title><source>Nature Immunology</source><volume>7</volume><fpage>1334</fpage><lpage>1342</lpage><pub-id pub-id-type="doi">10.1038/ni1402</pub-id><pub-id pub-id-type="pmid">17057721</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiche Salinas</surname><given-names>TR</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Sarnello</surname><given-names>D</given-names></name><name><surname>Zhyvoloup</surname><given-names>A</given-names></name><name><surname>Marchand</surname><given-names>LR</given-names></name><name><surname>Fert</surname><given-names>A</given-names></name><name><surname>Planas</surname><given-names>D</given-names></name><name><surname>Lodha</surname><given-names>M</given-names></name><name><surname>Chatterjee</surname><given-names>D</given-names></name><name><surname>Karwacz</surname><given-names>K</given-names></name><name><surname>Oxenford</surname><given-names>S</given-names></name><name><surname>Routy</surname><given-names>J-P</given-names></name><name><surname>Irlbeck</surname><given-names>D</given-names></name><name><surname>Amrine-Madsen</surname><given-names>H</given-names></name><name><surname>Ancuta</surname><given-names>P</given-names></name><name><surname>Fassati</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Th17 cell master transcription factor RORC2 regulates HIV-1 gene expression and viral outgrowth</article-title><source>PNAS</source><volume>118</volume><elocation-id>e48</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2105927118</pub-id><pub-id pub-id-type="pmid">34819367</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>VH</given-names></name><name><surname>Nordin</surname><given-names>JML</given-names></name><name><surname>Nguyen</surname><given-names>S</given-names></name><name><surname>Joy</surname><given-names>J</given-names></name><name><surname>Mampe</surname><given-names>F</given-names></name><name><surname>Del Rio Estrada</surname><given-names>PM</given-names></name><name><surname>Torres-Ruiz</surname><given-names>F</given-names></name><name><surname>GonzÃ¡lez-Navarro</surname><given-names>M</given-names></name><name><surname>Luna-Villalobos</surname><given-names>YA</given-names></name><name><surname>Ãvila-RÃ­os</surname><given-names>S</given-names></name><name><surname>Reyes-TerÃ¡n</surname><given-names>G</given-names></name><name><surname>Tebas</surname><given-names>P</given-names></name><name><surname>Montaner</surname><given-names>LJ</given-names></name><name><surname>Bar</surname><given-names>KJ</given-names></name><name><surname>Vella</surname><given-names>LA</given-names></name><name><surname>Betts</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Profound phenotypic and epigenetic heterogeneity of the HIV-1-infected CD4<sup>+</sup> T cell reservoir</article-title><source>Nature Immunology</source><volume>24</volume><fpage>359</fpage><lpage>370</lpage><pub-id pub-id-type="doi">10.1038/s41590-022-01371-3</pub-id><pub-id pub-id-type="pmid">36536105</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>B</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Jung</surname><given-names>SW</given-names></name><name><surname>Park</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Single-cell lineage tracing approaches to track kidney cell development and maintenance</article-title><source>Kidney International</source><volume>105</volume><fpage>1186</fpage><lpage>1199</lpage><pub-id pub-id-type="doi">10.1016/j.kint.2024.01.045</pub-id><pub-id pub-id-type="pmid">38554991</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Meyer</surname><given-names>CA</given-names></name><name><surname>Eeckhoute</surname><given-names>J</given-names></name><name><surname>Johnson</surname><given-names>DS</given-names></name><name><surname>Bernstein</surname><given-names>BE</given-names></name><name><surname>Nusbaum</surname><given-names>C</given-names></name><name><surname>Myers</surname><given-names>RM</given-names></name><name><surname>Brown</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>XS</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Model-based analysis of ChIP-seq (MACS)</article-title><source>Genome Biology</source><volume>9</volume><elocation-id>R137</elocation-id><pub-id pub-id-type="doi">10.1186/gb-2008-9-9-r137</pub-id><pub-id pub-id-type="pmid">18798982</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zicari</surname><given-names>S</given-names></name><name><surname>Sessa</surname><given-names>L</given-names></name><name><surname>Cotugno</surname><given-names>N</given-names></name><name><surname>Ruggiero</surname><given-names>A</given-names></name><name><surname>Morrocchi</surname><given-names>E</given-names></name><name><surname>Concato</surname><given-names>C</given-names></name><name><surname>Rocca</surname><given-names>S</given-names></name><name><surname>Zangari</surname><given-names>P</given-names></name><name><surname>Manno</surname><given-names>EC</given-names></name><name><surname>Palma</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Immune activation, inflammation, and non-AIDS co-morbidities in HIV-infected patients under long-term ART</article-title><source>Viruses</source><volume>11</volume><elocation-id>200</elocation-id><pub-id pub-id-type="doi">10.3390/v11030200</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.104856.3.sa0</article-id><title-group><article-title>eLife Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hong</surname><given-names>Seunghee</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Yonsei University</institution><country>Republic of Korea</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Convincing</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Important</kwd></kwd-group></front-stub><body><p>This study presents <bold>important</bold> findings that enhance our understanding of immune cell interactions in the context of chronic HIV-1 infection. The evidence supporting the conclusions is <bold>convincing</bold>. The authors have employed appropriate and validated methodologies, including detailed data reprocessing and batch correction to account for inter-donor variability. The inclusion of supplementary figures and analyses, such as cell communication inference, further substantiates the robustness of the findings. Overall, this work contributes to our understanding of HIV-1 immune evasion and highlights potential therapeutic targets for reservoir eradication.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.104856.3.sa1</article-id><title-group><article-title>Reviewer #2 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>The authors observed gene ontologies associated with upregulated KLF2 target genes in HIV-1 RNA+ CD4 T Cells using scRNA-seq and scATAC-seq datasets from the PBMCs of early HIV-1-infected patients, showing immune responses contributing to HIV pathogenesis and novel targets for viral elimination.</p><p>Strengths:</p><p>The authors carried out detailed transcriptomics profiling with scRNA-seq and scATAC-seq datasets to conclude upregulated KLF2 target genes in HIV-1 RNA+ CD4 T Cells.</p><p>Comments on revisions:</p><p>The authors justified my comments.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.104856.3.sa2</article-id><title-group><article-title>Reviewer #3 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>The revised manuscript demonstrates a marked improvement over the previous version. The authors have successfully incorporated feedback, and have moreover expanded their analyses.</p><p>The Methods section is now more detailed and meets the requirements for reproducible research. Authors have reprocessed the data, creating an integrated dataset using a previously published single-cell RNA-Seq atlas, which includes both healthy donors and individuals with chronic HIV-1 infection. An additional batch correction step was included into the processing pipeline after the explicit analysis of inter-donor variability within immune subsets, as was suggested.</p><p>Several supplementary figures were added, which both improve the understanding of data and address questions raised by the reviewers. The manuscript also provides additional analysis of cell communication inference, as suggested. The study of interactions between NK cells and infected CD4+ T cells, as well as between monocytes and infected CD4+ T cells, is valuable for understanding the influence of cell signaling on antiviral response and the production of HIV-1 transcripts in infected cells.</p><p>The authors have addressed all the reviewers' suggestions, and the current version of the manuscript is both more comprehensive and more informative. Additional analysis has strengthened the narrative and the reproducibility of the research.</p><p>The resulting manuscript is both more robust and more informative.</p></body></sub-article><sub-article article-type="author-comment" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.104856.3.sa3</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Dayeon</given-names></name><role specific-use="author">Author</role><aff><institution>Gwangju Institute of Science and Technology</institution><addr-line><named-content content-type="city">Gwangju</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Choi</surname><given-names>Sin Young</given-names></name><role specific-use="author">Author</role><aff><institution>Gwangju Institute of Science and Technology</institution><addr-line><named-content content-type="city">Gwangju</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Shin</surname><given-names>So-I</given-names></name><role specific-use="author">Author</role><aff><institution>Gwangju Institute of Science and Technology</institution><addr-line><named-content content-type="city">Gwangju</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>An</surname><given-names>Hyunsu</given-names></name><role specific-use="author">Author</role><aff><institution>Gwangju Institute of Science and Technology</institution><addr-line><named-content content-type="city">Gwangju</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Choi</surname><given-names>Byeong-Sun</given-names></name><role specific-use="author">Author</role><aff><institution>Korea Disease Control and Prevention Agency</institution><addr-line><named-content content-type="city">Daejeon</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Park</surname><given-names>Jihwan</given-names></name><role specific-use="author">Author</role><aff><institution>Gwangju Institute of Science and Technology</institution><addr-line><named-content content-type="city">Gwangju</named-content></addr-line><country>Republic of Korea</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authorsâ response to the original reviews.</p><disp-quote content-type="editor-comment"><p><bold>Public Reviews:</bold></p><p><bold>Reviewer #1 (Public review):</bold></p><p>Summary:</p><p>The authors aimed to elucidate the molecular mechanisms underlying HIV-1 persistence and host immune dysfunction in CD4+ T cells during early infection (&lt;6 months). Using single-cell multi-omics technologies-including scRNA-seq, scATAC-seq, and single-cell multiome analyses-they characterized the transcriptional and epigenomic landscapes of HIV-1-infected CD4+ T cells. They identified key transcription factors (TFs), signaling pathways, and T cell subtypes involved in HIV-1 persistence, particularly highlighting KLF2 and Th17 cells as critical regulators of immune suppression. The study provides new insights into immune dysregulation during early HIV-1 infection and reveals potential epigenetic regulatory mechanisms in HIV-1-infected T cells.</p><p>Strengths:</p><p>The study excels through its innovative integration of single-cell multi-omics technologies, enabling detailed analysis of gene regulatory networks in HIV-1-infected cells. Focusing on early infection stages, it fills a crucial knowledge gap in understanding initial immune responses and viral reservoir establishment. The identification of KLF2 as a key transcription factor and Th17 cells as major viral reservoirs, supported by comprehensive bioinformatics analyses, provides robust evidence for the study's conclusions. These findings have immediate clinical relevance by identifying potential therapeutic targets for HIV-1 reservoir eradication.</p></disp-quote><p>We sincerely appreciate the reviewerâs positive evaluation of our work.</p><disp-quote content-type="editor-comment"><p>Weaknesses:</p><p>Despite its strengths, the study has several limitations. By focusing exclusively on CD4+ T cells, the study overlooks other relevant immune cells such as CD14+ monocytes, NK cells, and B cells. Additionally, while the authors generated their own single-cell datasets, they need to validate their findings using other publicly available single-cell data from HIV-1-infected PBMCs.</p></disp-quote><p>Thank you to Reviewer #1 for your feedback on our work. In response to this feedback, we have examined cell-cell interactions between HIV-1-infected CD4+ T cells and other innate immune cells, including monocytes and NK cells. We identified altered interaction signaling patterns (e.g., MIF, ICAM2, CCL5, CLEC2B) that contribute to immune dysfunction and viral persistence (page 9, Supplementary Fig. 5)In addition, we validated the expression of KLF2 and its target genes using a publicly available scRNA-seq dataset from HIV-1-infected PBMCs [1], which includes both healthy donors and individuals with chronic HIV-1 infection. The upregulation of key KLF2 targets in HIV-1-infected CD4+ T cells from this dataset supports the reproducibility of our findings. We have incorporated into the revised Results, Discussion, and Supplementary Materials (page 8, page 12 and Supplementary Fig. 4A).</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Public review):</bold></p><p>Summary:</p><p>The authors observed gene ontologies associated with upregulated KLF2 target genes in HIV-1 RNA+ CD4 T Cells using scRNA-seq and scATAC-seq datasets from the PBMCs of early HIV-1-infected patients, showing immune responses contributing to HIV pathogenesis and novel targets for viral elimination.</p><p>Strengths:</p><p>The authors carried out detailed transcriptomics profiling with scRNA-seq and scATAC-seq datasets to conclude upregulated KLF2 target genes in HIV-1 RNA+ CD4 T Cells.</p></disp-quote><p>We thank the reviewer for highlighting the strengths of our work.</p><disp-quote content-type="editor-comment"><p>Weaknesses:</p><p>This key observation of up-regulation KLF2 associated genes family might be important in the HIV field for early diagnosis and viral clearance. However, with the limited sample size and in-vivo study model, it will be hard to conclude. I highly recommend increasing the sample size of early HIV-1-infected patients.</p></disp-quote><p>Thank you to Reviewer #2 for this important comment. We acknowledge the limitations of our modest sample size, which reflects the challenges of recruiting well-characterized individuals in early HIV-1 infection (&lt;6 months) and obtaining high-quality PBMCs for single-cell multi-omic profiling. To strengthen our findings, we validated the upregulation of KLF2 target genes using a publicly available scRNA-seq dataset from HIV-1-infected PBMCs [1], which showed similar expression patterns in HIV-1 RNA+ CD4+ T cells (page 8 and Supplementary Fig. 4A).</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3 (Public review):</bold></p><p>Summary:</p><p>This manuscript studies intracellular changes and immune processes during early HIV-1 infection with an additional focus on the small CD4+ T cell subsets. The authors used single-cell omics to achieve high resolution of transcriptomic and epigenomic data on the infected cells which were verified by viral RNA expression. The results add to understanding of transcriptional regulation which may allow progression or HIV latency later in infected cells. The biosamples were derived from early HIV infection cases, providing particularly valuable data for the HIV research field.</p><p>Strengths:</p><p>The authors examined the heterogeneity of infected cells within CD4 T cell populations, identified a significant and unexpected difference between naive and effector CD4 T cells, and highlighted the differences in Th2 and Th17 cells. Multiple methods were used to show the role of the increased KLF2 factor in infected cells. This is a valuable finding of a new role for the major transcription factor in further disease progression and/or persistence.</p><p>The methods employed by the authors are robust. Single-cell RNA-Seq from PBMC samples was followed by a comprehensive annotation of immune cell subsets, 16 in total. This manuscript presents to the scientific community a valuable multi-omics dataset of good quality, which could be further analyzed in the context of larger studies.</p></disp-quote><p>We sincerely thank the reviewer for the insightful and concise summary of our work.</p><disp-quote content-type="editor-comment"><p>Weaknesses:</p><p>Methods and Supplementary materials</p><p>Some technical aspects could be described in more detail. For example, it is unclear how the authors filtered out cells that did not pass quality control, such as doublets and cells with low transcript/UMI content. Next, in cell annotation, what is the variability in cell types between donors? This information is important to include in the supplementary materials, especially with such a small sample size. Without this, it is difficult to determine, whether the differences between subsets on transcriptomic level, viral RNA expression level, and chromatin assessment are observed due to cell type variations or individual patient-specific variations. For the DEG analysis, did the authors exclude the most variable genes?</p></disp-quote><p>Thank you to Reviewer #3 for these detailed comments and observations. In the revised Methods section (page 16), we have added information on our quality control filtering process. Specifically, we excluded cells with fewer than 200 detected genes, high mitochondrial content (&gt;30%), or low UMI counts. Doublets were identified and removed using DoubletFinder.</p><p>To address inter-donor variability, we included a new supplementary figure (Supplementary Fig. 1B) showing the distribution of major immune cell types across individual donors. While we observed some variation in cell-type composition between individuals, this likely reflects natural biological heterogeneity in early HIV-1 infection. Additionally, we applied fastMNN batch correction to mitigate donor-specific technical variation. After correction, the overall patterns of gene expression within each major CD4+ T cell subset were consistent across individuals (Supplementary Fig. 1C).</p><p>Regarding the DEG analysis, we used âFindMarkersâ function in Seurat (v.3.2.1), which does not exclude highly variable genes. These details have been clarified in the updated Methods section (page 18).</p><disp-quote content-type="editor-comment"><p>The annotation of 16 cell types from PBMC samples is impressive and of good quality, however, not all cell types get attention for further analysis. Itâs natural to focus primarily on the CD4 T cells according to the research objectives. The authors also study potential interactions between CD4 and CD8 T cells by cell communication inference. It would be interesting to ask additional questions for other underexplored immune cell subsets, such as: (1) Could viral RNA be detected in monocytes or macrophages during early infection? (2) What are the inferred interactions between NK cells and infected CD4 T cells, are interactions similar to CD4-CD8 results? (3) What are the inferred interactions between monocytes or macrophages and infected CD4 T cells?</p></disp-quote><p>In line with our study objectives, we initially focused on CD4+ T cells as primary HIV-1 targets. However, in response to the reviewerâs comment, we examined the inferred communications between HIV-1-infected CD4+ T cells and other immune cells.</p><p>(1) With regard to the presence of viral RNA in monocytes or macrophages, we observed negligible HIV-1 RNA signal in these cell types in our dataset, consistent with their low permissiveness in early-stage infection [2]. However, we acknowledge the limitations of detecting rare infected cells at the single-cell level.</p><p>(2) We identified increased MIF and ICAM2 signaling between NK cells and HIV-1-infected CD4+ T cells, which are associated with KLF2-mediated immune modulation. These patterns are consistent with the CD4âCD8 interaction results observed in our dataset. (Supplementary Fig. 5A)</p><p>(3) Through the cell-cell interaction analysis with differential expression analysis, we inferred reduced CCL5 and CD55 signaling between monocytes and HIV-1-infected CD4+ T cells (Supplementary Fig. 5B). These reductions may potentially impair immune responses and antiviral defense.</p><p>We appreciate the reviewerâs suggestions and believe that the analysis of underexplored immune subsets strengthens the relevance of our findings. These results have been incorporated into the revised Results (page 9).</p><disp-quote content-type="editor-comment"><p>Discussion</p><p>It would be interesting to see more discussion of the observation of how naÃ¯ve T cells produce more viral RNA compared to effector T cells. It seems counterintuitive according to general levels of transcriptional and translational activity in subsets.</p><p>Another discussion block could be added regarding the results and conclusion comparison with Ashokkumar et al. paper published earlier in 2024 (10.1093/gpbjnl/qzae003). This earlier publication used both a cell line-based HIV infection model and primary infected CD4 T cells and identified certain transcription factors correlated with viral RNA expression.</p></disp-quote><p>Thank you to Reviewer #3 for the insightful suggestions. We observed that the proportion of HIV-1-infected naÃ¯ve CD4 T cells is higher compared to effector T cells. Although effector CD4 T cells are generally more active, previous studies have suggested that naÃ¯ve CD4 T cells are susceptible to HIV-1 infection during early infection that may associate with initial expansion and rapid progression [3, 4]. This may be due to less restriction by antiviral signaling or more accessible chromatin states in resting cells. We have added this context and cited relevant papers to address this observation (page 11)</p><p>In addition, we have incorporated a comparative discussion with the recent study [5], which identified FOXP1 and GATA3 as transcriptional regulators associated with HIV-1 RNA expression. While these TFs were not significantly differentially expressed in our dataset, we discuss potential reasons for this discrepancyâincluding differences in infection model (in vitro vs. ex vivo), infection stage (latency vs. acute), and T cell subset compositionâand emphasize that both studies highlight the importance of transcriptional regulation in HIV-1 persistence (page 12 and Supplementary Fig. 4B).</p><disp-quote content-type="editor-comment"><p><bold>Recommendations for the authors:</bold></p><p><bold>Reviewer #1 (Recommendations for the authors):</bold></p><p>The study has several notable limitations.</p><p>First, it was restricted to early-stage HIV-1 infection (&lt;6 months) without longitudinal data, preventing the authors from capturing temporal changes in immune cell populations, gene expression profiles, and epigenetic landscapes throughout disease progression.</p></disp-quote><p>Thank you to Reviewer #1 for this important limitation. As noted, our study focused exclusively on early-stage HIV-1 infection (&lt;6 months) to capture the initial immune dysregulation and epigenetic alterations. We agree that longitudinal analysis would provide valuable insights into disease progression. However, due to the limited availability of early-infection patient samples suitable for performing multi-omics profiling, we prioritized capturing a detailed snapshot at this early stage. To address this limitation, future studies incorporating longitudinal samplingâincluding chronic infection and long-term non-progressorsâwill be essential to fully elucidate the temporal dynamics of HIV-1 pathogenesis.</p><disp-quote content-type="editor-comment"><p>Second, while the bioinformatic analysis compared &quot;Uninfected&quot; and &quot;HIV-1-infected&quot; cells from patients, the authors could have strengthened their findings by incorporating publicly available single-cell data from healthy donors and chronically infected HIV-1 patients to validate their arguments across all figures.</p></disp-quote><p>To support the robustness of our findings, we incorporated a publicly available single-cell RNA-seq dataset [1], which includes both healthy donors and individuals with chronic HIV-1 infection. In this dataset, we validated the upregulation of KLF2 and its target genes in HIV-1-infected CD4+ T cells and observed generally consistent expression patterns with those in our early-infection cohort (page 8; page 12 and Supplementary Fig. S4). While not all gene-level trends were identically reflecting differences in infection stage and immune activation status, this external comparison reinforces the reproducibility of key observations and highlights the unique transcriptional features associated with early HIV-1 infection.</p><disp-quote content-type="editor-comment"><p>Third, although the study focused on CD4+ T cells as primary HIV-1 targets, it overlooked other important immune cells such as CD8+ T cells, monocytes, and NK cells, which may contribute to viral persistence and immune dysfunction through cell-cell interactions.</p></disp-quote><p>In the revised manuscript, we expanded our analysis to include predicted ligandâreceptor interactions between HIV-1-infected and uninfected CD4+ T cells with innate and cytotoxic immune cells using CellChat v.2.1.1. Specifically, we evaluated interactions with NK cells and monocytes and identified altered signaling pathways such as MIF, ICAM2, CCL5, and CLEC2B, which are associated with immune modulation (Supplementary Fig. 5A). We have added these results to the revised Results (page 9).</p><disp-quote content-type="editor-comment"><p>Lastly, comparing these findings with other chronic viral infections (e.g., HBV, HCV) would have positioned this work more effectively within the broader field of viral immunology and enhanced its impact.</p></disp-quote><p>We agree that broader comparisons with other chronic viral infections could enhance the impact of our findings. In the current discussion, we noted similarities in interferon signaling disruption with viruses such as HCV and HSV. (page 11). Our observation that HIV-1-infected CD4+ T cells exhibit impaired interferon responses is consistent with immune evasion mechanisms reported in HCV and HSV infections. These results underscore both the shared and specific features of immune modulation and persistence during HIV-1 early infection.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3 (Recommendations for the authors):</bold></p><p>Supplementary Table S1 should indicate which technique was used for sequencing. However, the current version of the table marks no protocol applied to the majority of the samples, which is confusing and needs to be corrected.</p></disp-quote><p>Thank you to Reviewer #3 for pointing out this important oversight. We have revised Supplementary Table S1 to clearly indicate the sequencing method used for each sample. Separate columns for scRNA-seq, scATAC-seq, and sc-Multiome now specify whether each technique was applied (âYesâ or âNoâ) to improve clarity and transparency.</p><p>(1) Wang, S., et al., An atlas of immune cell exhaustion in HIV-infected individuals revealed by single-cell transcriptomics. Emerg Microbes Infect, 2020. 9(1): p. 2333-2347.</p><p>(2) Arfi, V., et al., Characterization of the early steps of infection of primary blood monocytes by human immunodeficiency virus type 1. J Virol, 2008. 82(13): p. 6557-65.</p><p>(3) Douek, D.C., et al., HIV preferentially infects HIV-specific CD4+ T cells. Nature, 2002. 417(6884): p. 95-8.</p><p>(4) Jiao, Y., et al., Higher HIV DNA in CD4+ naive T-cells during acute HIV-1 infection in rapid progressors. Viral Immunol, 2014. 27(6): p. 316-8.</p><p>(5) Ashokkumar, M., et al., Integrated Single-cell Multiomic Analysis of HIV Latency Reversal Reveals Novel Regulators of Viral Reactivation. Genomics Proteomics Bioinformatics, 2024. 22(1).</p></body></sub-article></article>